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A B S T R A C T
Background
Insecticide-treated nets (ITNs) and indoor residual spraying (IRS) are used to control malaria vectors. Both strategies use insecticides
to kill mosquitoes that bite and rest indoors. For ITNs, the World Health Organization (WHO) only recommended pyrethroids until
2018, but mosquito vectors are becoming resistant to this insecticide. For IRS, a range of insecticides are recommended. Adding IRS
to ITNs may improve control, simply because two interventions may be better than one; it may improve malaria control where ITNs
are failing due to pyrethroid resistance; and it may slow the emergence and spread of pyrethroid resistance.
Objectives
To summarize the effect on malaria of additionally implementing IRS, using non-pyrethroid-like or pyrethroid-like insecticides, in
communities currently using ITNs.
Search methods
We searched the Cochrane Infectious Diseases Group Specialized Register; the Cochrane Central Register of Controlled Trials (CEN-
TRAL); MEDLINE; Embase; LILACS; theWHO International Clinical Trials Registry Platform; ClinicalTrials.gov; and the ISRCTN
registry up to 18 March 2019.
Selection criteria
Cluster-randomized controlled trials (cRCTs), interrupted time series (ITS), or controlled before-and-after studies (CBAs) comparing
IRS plus ITNs with ITNs alone.
Data collection and analysis
Two review authors independently assessed trials for eligibility, analyzed risk of bias, and extracted data. We used risk ratio (RR) and
95% confidence intervals (CI). We stratified by type of insecticide: ‘non-pyrethroid-like’, as this could improve malaria control better
than adding IRS insecticides that have the same way of working as the insecticide on ITNs (‘pyrethroid-like’). We used subgroup
analysis of ITN usage in the trials to explore heterogeneity. We assessed the certainty of evidence using the GRADE approach.
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Main results
Six cRCTs (eight comparisons) met our inclusion criteria conducted since 2008 in sub-Saharan Africa. Malaria transmission in all sites
was from mosquitoes belonging to the Anopheles gambiae s.l. complex species; two trials in Benin and Tanzania also reported the vector
Anopheles funestus. Three trials used insecticide with targets different to pyrethroids (two used bendiocarb and one used pirimiphos-
methyl); two trials used dichloro-diphenyl-trichlorethane (DDT), an insecticide with the same target as pyrethroids; and one trial used
both types of insecticide (pyrethroid deltamethrin in the first year, switching to bendiocarb for the second-year). ITN usage was greater
than 50% in three trials, and less than 50% in the remainder.
Indoor residual spraying using ‘non-pyrethroid-like’ insecticides
Adding IRS with a non-pyrethroid-like insecticide had mixed results. Overall, we do not know if the addition of IRS impacted on
malaria incidence (rate ratio 0.93, 95% CI 0.46 to 1.86; 2 cRCTs, 566 child-years; very low-certainty evidence); it may have reduced
malaria parasite prevalence (0.67, 95%CI 0.35 to 1.28; 5 comparisons from 4 cRCTs, 10,440 participants; low-certainty evidence); and
it may have reduced the prevalence of anaemia (RR CI 0.46, 95% 0.18 to 1.20; 3 comparisons from 2 cRCTs, 2026 participants; low-
certainty evidence). Three trials reported the impact on EIR, with variable results; overall, we do not know if IRS had any effect on the
EIR in communities using ITNs (very low-certainty evidence). Trials also reported the adult mosquito density and the sporozoite rate,
but we could not summarize or pool these entomological outcomes due to unreported data. ITN usage did not explain the variation
in malaria outcomes between different studies. One trial reported no effect on malaria incidence or parasite prevalence in the first year,
when the insecticide used for IRS had the same target as pyrethroids, but showed an effect on both outcomes in the second year, when
the insecticide was replaced by one with a different target.
Two trials measured the prevalence of pyrethroid resistance before and after IRS being introduced: no difference was detected, but these
data are limited.
Indoor residual spraying using ‘pyrethroid-like’ insecticides
Adding IRS using a pyrethroid-like insecticide did not appear to markedly alter malaria incidence (rate ratio 1.07, 95% CI 0.80 to
1.43; 2 cRCTs, 15,717 child-years; moderate-certainty evidence), parasite prevalence (RR 1.11, 95% CI 0.86 to 1.44; 3 cRCTs, 10,820
participants; moderate-certainty evidence), or anaemia prevalence (RR 1.12, 95% CI 0.89 to 1.40; 1 cRCT, 4186 participants; low-
certainty evidence). Data on the entomological inoculation rate (EIR) were limited, and therefore we do not know if IRS had any effect
on the EIR in communities using ITNs (very low-certainty evidence).
Authors’ conclusions
Four trials have evaluated adding IRS using ‘non-pyrethroid-like’ insecticides in communities using ITNs. Some of these trials showed
effects, and others did not. Three trials have evaluated adding IRS using ‘pyrethroid-like’ insecticides in communities using ITNs, and
these studies did not detect an additional effect of the IRS. Given the wide geographical variety of malaria endemicities, transmission
patterns, and insecticide resistance, we need to be cautious with inferences to policy from the limited number of trials conducted to
date, and to develop relevant further research to inform decisions.
P L A I N L A N G U A G E S U M M A R Y
Adding indoor residual spraying in communities using insecticide-treated nets for the prevention of malaria
What was the aim of this review?
Indoor residual spraying (IRS) is the regular application of chemical insecticides to household walls. The insecticide lasts for at least
four months, killing mosquitoes that land on them. Insecticide-treated nets (ITNs) are bed nets treated with insecticides, preventing
mosquitoes from biting people and reducing the mosquito population. Both interventions help to control malaria by reducing the
number of people being bitten by mosquitoes infected with malaria. Implementing IRS in communities that are using ITNs may be
better for malaria control than using ITNs alone for three reasons: two interventions may be better than one; it may improve malaria
control where mosquitoes have become resistant to the pyrethroid insecticides used in ITNs; and the combination of ITNs and IRS
may also help to slow the emergence of pyrethroid resistance (where pyrethroids are no longer effective at killing mosquitoes).
Pyrethroids were the only class of insecticides approved for use in ITNs until 2018, but growing resistance to pyrethroids impairs their
effectiveness. The addition of IRS could counteract this reduction in ITN effectiveness. We could expect that IRS insecticides that
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have a different way of working to pyrethroids (‘non-pyrethroid-like’) could restore effectiveness better than those that have the same
way of working (‘pyrethroid-like’). The aim of this review was to summarize the impact of pyrethroid-like or non-pyrethroid-like IRS
on malaria, when implemented in communities that are using ITNs.
Key messages
When IRS was conducted with a non-pyrethroid-like insecticide, some studies and outcomes suggested an impact, but this was not
consistent. Factors such as the number of people using nets did not explain the differences between studies. When a pyrethroid-like
insecticide was used for IRS, data were limited but there was no additional effect demonstrated.
What was studied in the review?
We searched for trials that evaluated the impact on malaria transmission when IRS, using a World Health Organization (WHO)-
recommended dosage, was implemented in communities that were using either ready-treated ITN products or standard nets treated
with insecticide at a WHO-recommended dose. We considered effects on both human health outcomes and on mosquito populations.
What were the main results of the review?
In total, we identified six trials matching our inclusion criteria, from which eight comparisons were drawn. Three trials (providing four
comparisons) used a non-pyrethroid-like IRS throughout the study, and two trials (providing two comparisons) used a pyrethroid-like
IRS throughout. One further trial used a pyrethroid-like IRS in the first study year and switched to a non-pyrethroid-like IRS in the
subsequent years, therefore providing two different comparisons. All six trials were conducted in sub-Saharan Africa.
Adding non-pyrethroid-like IRS in communities using ITNs gave mixed results, with some trials detecting substantial effects but one
trial detecting no effect. Overall, the results from the four included trials found that there may be a reduction in malaria parasite
prevalence and anaemia prevalence (low-certainty evidence). We do not know if there is an impact on the malaria incidence or on the
number of infected bites received per person per year (very low-certainty evidence).
When adding pyrethroid-like IRS in communities using ITNs, the data from three trials indicate there is probably no effect on malaria
incidence or parasite prevalence (moderate-certainty evidence), and there may be little or no effect on the prevalence of anaemia. Data
on the number of infected bites received per person per year were too limited to draw a conclusion (very low-certainty evidence).
How up to date is the review?
We searched for relevant trials up to 18 March 2019.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Non-pyrethroid- like indoor residual spraying (IRS) + insecticide- treated nets (ITNs) versus ITNs alone for preventing malaria
Patient or population: people at risk of malaria
Setting: sub-Saharan Af rica (Benin, Tanzania, Sudan)
Intervention: combinat ion of IRS + ITNs - using an insect icide for IRS that has a dif ferent target site to the pyrethroids used in ITNs
Comparison: ITNs alone
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments:
The combination of IRS
and ITNs, when the in-
secticide used for IRS
has a different target
site to the pyrethroids
used in ITNsRisk with ITNs alone Risk with IRS + ITNs
Malaria incidence 317 cases per 1000
child-years
294 cases per 1000
child-years (145 to 589)
Rate ratio 0.93
(0.46 to 1.86)
566 child-years
(2 comparisons, 2
cRCTs)
⊕©©©
Very lowa,b
We do not know if there
is an ef fect on malaria
incidence compared to
ITNs alone
Malaria parasite preva-
lence
23.8 cases per 100 15.9 cases per 100 (8.3
to 30.4)
RR 0.67 (0.35 to 1.28) 10,440 part icipants
5 comparisons, 4
cRCTs)
⊕⊕©©
Lowa,c
May sometimes have
reduced malaria para-
site prevalence com-
pared to ITNs alone
EIR - - Mean EIR was lower
with IRS in 2 of the 3
trials.
(4 comparisons, 3
cRCTs)
⊕©©©
Very lowe,f
We did not know if there
was an ef fect on the EIR
compared to ITNs alone
Anaemia prevalence
(haemoglobin < 8 g/ dL)
4.7 cases per 100 2.1 cases per 100 (0.0
to 5.7)
RR 0.46
(0.18 to 1.20)
2026 part icipants
(3 comparisons, 2
cRCTs)
⊕⊕©©
Lowa,e
May have reduced
anaemia prevalence
compared to ITNs
alone.
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*The risk in the intervention arm (and its 95%CI) is based on the assumed risk in the comparison arm and the relative effect of the intervent ion (and its 95%CI). The assumed
risk of the comparison arm is calculated f rom the total number of events/ total number of part icipants in the control arms of the trials contribut ing to the meta-analysis
CI: conf idence interval; cRCT: cluster randomized controlled trial; EIR: entomological inoculat ion rate; IRS: indoor residual spraying; ITN: insect icide-treated net; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious imprecision: the CIs were wide and included both substant ive increases and decreases in
the outcome.
bDowngraded two levels for very serious inconsistency: there were two trials in the subgroup, report ing direct ly contrast ing
ef fects. This was represented by the I² value of 84%within the subgroup.
cDowngraded one level for serious inconsistency: three trials demonstrated an ef fect and one trial did not. Consequent ly,
there was considerable qualitat ive heterogeneity with an I² value of 86%within the subgroup.
dDowngraded one level for serious inconsistency: large dif ferences in ef fect est imates were reported in the three studies.
eDowngraded one level for serious inconsistency: there was moderate heterogeneity with an I² value of 41% within the
subgroup. One study reported a substant ial reduct ion in anaemia and another reported a moderate reduct ion. One comparison
in the subgroup showed no ef fect by adding IRS, though it should be noted this comparison assessed the addit ion of IRS to
pyrethroid-piperonyl butoxide nets.
fDowngraded two levels for very serious imprecision: where provided, the CIs for the mean EIR in the intervent ion arms were
very wide, including values that would represent both large increases and reduct ions f rom the mean EIR in the control arms.
The trial showing the greatest reduct ion in EIR did not report CIs for this outcome and it is, therefore, dif f icult to assess the
precision (Protopopof f 2018).
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B A C K G R O U N D
Description of the condition
Between 2000 and 2015, malaria deaths halved globally. In this
time, malaria control interventions were estimated to have averted
663 million cases of malaria, with much of the progress considered
to be due to improved vector control (Bhatt 2015). Despite this
decline, the disease is still a leading cause of mortality, responsible
for 445,000 deaths worldwide in 2016 (WHO 2017a).
Description of the intervention
Vector control depends largely on insecticides, primarily deliv-
ered as indoor residual spraying (IRS) or insecticide-treated nets
(ITNs). IRS is the regular spraying of insecticides to the indoor
walls of houses. The insecticide lasts for at least fourmonths, killing
mosquitoes that land on it. ITNs are bed nets treated with insec-
ticides, preventing mosquitoes from biting people and reducing
the mosquito population. ITNs include long-lasting insecticidal
nets (LLINs), where the insecticide lasts for up to three years, and
conventionally treated nets, where the insecticide is active for up
to 12 months. Up until 2018, only pyrethroid class insecticides
were considered safe enough to be used for ITNs (Zaim 2000).
However, the non-insecticide chemical piperonyl butoxide (PBO)
can also be added to ITNs, making them more effective at killing
mosquitoes in areas where the mosquito populations are highly
resistant to pyrethroids (Gleave 2018). Insecticides used for IRS
are less restricted, as people living in the households are considered
less likely to come into contact with the treated walls than with
the fabric of a bed net.
Pyrethroids target the mosquito voltage-gated sodium ion chan-
nels. If mosquito resistance to pyrethroids is leading to reduced
effectiveness of ITNs, IRS using insecticides with different target
sites (‘non-pyrethroid-like’ insecticides) may be less affected by the
pyrethroid resistance andmore likely to have an impact onmalaria
transmission. In contrast, IRS using insecticides that also target
the voltage-gated sodium ion channels (‘pyrethroid-like’ insecti-
cides) may be less likely to have an impact.
How the intervention might work
IRS with dichloro-diphenyl-trichlorethane (DDT) was the main
intervention of the malaria eradication programmes in the mid-
20th century (Pluess 2010). When malaria was eliminated from
many parts of South America, Europe, and Asia, IRS was an in-
tegral part of the elimination strategies (Pluess 2010). However,
many countries today choose to adopt ITNs rather than IRS, as
they are logistically easier to implement than IRS and more ac-
ceptable to communities.
Theoretically, the simultaneous use of IRS and ITNs is better for
malaria control than using ITNs alone for three reasons. First, we
might expect an incremental effect of using two vector control
interventions over one, particularly when the target vector species
both feeds and rests indoors (endophagic and endophilic vectors).
As withmany vector control interventions, the reality is not simple
and the success of the intervention will depend on both human
and vector behaviour (Killeen 2006). Mosquito exophily can re-
duce the effectiveness of IRS and ITNs, as mosquitoes that rest
outdoors more will have less contact with an indoor treated wall
or net (Kitau 2012). Earlier biting times of Anopheles spp have also
been observed, which can increase the likelihood of a mosquito
encountering a human to bite and reduce the impact of ITNs
(Ojuka 2015).
Second, implementing IRS in communities currently using ITNs
may be beneficial for the management of mosquito resistance to
insecticides. Malaria control programmes may additionally imple-
ment IRS as a reactive measure in response to high pyrethroid
resistance in Anopheles mosquitoes. The addition of IRS, particu-
larly with non-pyrethroid-like insecticides, could mitigate for this
reduction in ITN effectiveness.
Third, policy-makers could also introduce a combination of the
two interventions proactively, administering a non-pyrethroid-like
IRS alongside ITNs as part of an insecticide resistance manage-
ment (IRM) strategy to delay the emergence of pyrethroid resis-
tance (WHO 2012).
Why it is important to do this review
The combination of IRS and ITNs can be logistically complicated
to deliver. ITNs are advantageous because they can last for three
to five years, and because net distribution campaigns can be con-
ducted at a village central point or community health centre. In
contrast, the current set of insecticides used for IRS will remain
active for six months at best, and an effective spray campaign in a
setting with perennial malaria transmission will therefore require
several sprays per year (WHO 2015a). IRS is also logistically more
demanding, requiring a visit to every individual household. IRS
programmes typically take a substantially higher amount of finan-
cial commitment than an ITN distribution campaign, in part due
to the sheer quantity of insecticide required at programmatic scales
(Goodman 2001). Finally, IRS has experienced more problems
with the acceptability of the intervention and its delivery than
ITNs (Kleinschmidt 2009).
Advice has changed over time about whether or when the combi-
nation of IRS and ITNs should be used. In the past, the Global
Technical Strategy has recommended combining ITNs with IRS
for epidemic situations only (WHO 2015b). The current WHO
Elimination Framework continues to recommend that elimina-
tion programmes using ITNs as a core strategy maintain a capacity
to conduct IRS for the rapid clearance of transmission foci (WHO
2017b). However, it additionally recommends IRS is applied as a
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resistance management strategy in areas where ITNs are the pri-
mary intervention and vectors are resistant to pyrethroids. It is
recommended that IRS is applied in a rotation of different classes
of insecticide, though there is some ambiguity over when rotations
should be carried out. The framework also guides that IRS should
not be used to compensate for poor coverage of ITNs.
In the past few years, the effect of combining IRS with ITNs has
been contentious, with inconsistent results reported across differ-
ent trials. Modelling data has even suggested an antagonistic effect
of combining IRS with ITNs when ITN coverage is poor (Yakob
2011). A greater understanding of the effect on malaria trans-
mission is required to determine whether the additional logistical
complexity of combining IRS with ITNs is worthwhile.
O B J E C T I V E S
To summarize the effect on malaria of additionally implementing
IRS, using non-pyrethroid-like or pyrethroid-like insecticides, in
communities currently using ITNs.
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Randomized controlled trials (RCTs) with: the unit of
randomization being a cluster and at least two clusters per arm
(cRCTs). As the two interventions were distributed at a
community level, we did not expect to find trials with individual
randomization.
• Controlled before-and-after studies (CBAs) with: a
contemporaneous control arm and at least two sites per arm.
• Interrupted time series designs (ITS) with: a clearly defined
point in time when the intervention occurred and at least three
data points before and three after the intervention.
Types of participants
All people living in a rural or urban malarious area where ITNs are
in use. We included participants living in all levels of endemicity,
including both stable and unstable transmission.
Types of interventions
IRS using theWorldHealthOrganization (WHO)-recommended
dosage (see Table 1; WHO 2015a). We individually evaluated the
effects of IRS using:
• ‘non-pyrethroid-like insecticides’: those with alternative
targets such as acetylcholinesterase, in contrast to ITNs.
• ‘pyrethroid-like insecticides’: those that target the voltage-
gated sodium ion channels, similarly to ITNs;
ITNs interventions were required to be the same in both inter-
vention and control arms. Suitable ITNs included LLINs and
pyrethroid-PBO nets, with either a full or preliminary recommen-
dation by the WHO (Table 2), or conventionally treated nets,
treated with insecticide at theWHO-recommended dosage (Table
3).
Any other malaria control measures were required to be the same
in both intervention and control arms.
Types of outcome measures
Primary outcomes
Studies eligible for inclusion must have reported at least one of the
following.
• Malaria incidence: measured as a count per person unit
time of (a) infections or (b) new infections, following treatment
to avoid measuring pre-existing infections. Infection was defined
as any symptom, including fever, with confirmed parasitaemia
(by blood smear microscopy or rapid diagnostic test (RDT)).
• Malaria parasite prevalence: the proportion of surveyed
people with confirmed parasitaemia.
Secondary outcomes
Entomological
• Entomological inoculation rate (EIR): the estimated
number of bites by infectious mosquitoes per person per unit of
time. This was measured using the human biting rate (the
number of mosquitoes biting a person over a stated period
measured directly using human baits or indirectly using light
traps, knock-down catches, baited huts, or other methods of
biting rate determination) multiplied by the sporozoite rate.
• Sporozoite rate: the fraction of vector mosquitoes present
and biting that were considered infectious, measured by a
technique previously shown to be appropriate for the vector
(microscopy, immunoassays, polymerase chain reaction-based
assays or other methods).
• Adult mosquito density: measured by a technique
previously shown to be appropriate for the vector (human baits,
light traps, knock-down catches, baited huts, or other methods).
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Epidemiological
• Malaria-related deaths.
• Anaemia prevalence defined as per WHO cut-offs (WHO
2011).
• Hospital admissions for malaria.
• Number of people with severe malaria: using site-specific
definitions, provided they included (a) and either (b) or (c): (a)
demonstration of parasitaemia by blood smear; (b) symptoms of
cerebral malaria including coma, prostration or multiple seizures;
(c) severe, life-threatening anaemia (WHO 2015c).
• Number of people with uncomplicated clinical malaria
episodes: we will use site-specific definitions, provided they
include: (a) demonstration of malaria parasites by blood smear or
an RDT, or both; and (b) clinical symptoms including fever
detected passively or actively.
Mosquito insecticide resistance
• Level of insecticide resistance, confirmed by WHO cylinder
assays/Centers for Disease Control and Prevention (CDC) bottle
bioassays or molecular techniques. This included resistance to
either the class of insecticide used for IRS (that is, as an unwanted
outcome of trials due to increased coverage of insecticidal
interventions) or to pyrethroid insecticides (to monitor whether
the addition of IRS prevented or reduced resistance to ITNs).
Search methods for identification of studies
We attempted to identify all relevant trials regardless of language
or publication status (published, unpublished, in press, and in
progress).
Electronic searches
We searched the following databases up to 18 March 2019
using the search terms and strategy described in Appendix
1: Cochrane Infectious Diseases Group Specialized Register;
Cochrane Central Register of Controlled Trials (CENTRAL) Is-
sue 3, April 2019, published in the Cochrane Library; MED-
LINE (PubMed); Embase (Ovid); and LILACS (Bireme). We also
checked theWHO International Clinical Trials Registry Platform
(WHO ICTRP; www.who.int/ictrp/en/) and ClinicalTrials.gov (
clinicaltrials.gov/ct2/home) for ongoing trials, also on 18 March
2019, using the terms: indoor residual spraying; IRS; insecticide-
treated nets; bednets; ITNs; LLIN.
Searching other resources
We contacted researchers working in the field for unpublished
data. We also checked the reference lists of all trials identified by
the above methods.
Data collection and analysis
Selection of studies
Two review authors (LC and JP) independently assessed the titles
and abstracts of trials identified by the searches. The same two
review authors assessed full-text copies of potentially relevant tri-
als for inclusion using an eligibility form based on the inclusion
criteria. We compared the results of our assessments and resolved
any disagreements by discussion and consensus, with arbitration
by a third review author (PG) when necessary. We ensured that
multiple publications of the same trial were included once. We
listed excluded studies, together with their reasons for exclusion,
in the Characteristics of excluded studies table. We illustrated the
study selection process in a PRISMA diagram (Figure 1).
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Figure 1. Study flow diagram.
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Data extraction and management
Two review authors (LC and JP) independently extracted infor-
mation from the trials using prepiloted, electronic data extraction
forms. In case of differences in extracted data, the two review au-
thors discussed these differences to reach consensus. If unresolved,
we consulted a third review author (PG). In case of missing data,
we contacted the original study author(s) for clarification.
We extracted data on the following.
• Trial design: type of trial; method of participant selection;
adjustment for clustering (for cRCTs); sample size; method of
blinding of participants and personnel.
• Participants: trial settings and population characteristics;
recruitment rates; withdrawal and loss to follow-up.
• Intervention: description of intervention and control
(active ingredient, dose, formulation, method, frequency and
timing of application, buffer zone between clusters);
cointerventions; description of control; coverage of intervention,
control, and cointerventions; compliance of intervention,
control, and cointerventions.
• Outcomes: definition of outcome; diagnostic method or
surveillance method; passive or active case detection; duration of
follow-up; time points at which outcomes were assessed; number
of events; number of participants or unit time; statistical power;
unit of analysis; incomplete outcomes/missing data.
• Other:
◦ primary and secondary vector(s) species; vector(s)
behaviour (nature, stability, adult habitat, peak biting times,
exophilic/endophilic, exophagic/endophagic, anthropophilic/
zoophilic); method of mosquito collection(s); phenotypic
insecticide resistance (based on WHO definitions if
supplementary WHO cylinder assays or CDC bottle bioassays,
or both, were performed while the trial was running); genotypic
insecticide resistance profile (either performed during the trial or
if the trial referenced data from previous studies done on the
same local vector population within the previous five years);
◦ malaria endemicity; eco-epidemiological setting;
human population proximity to mosquito aquatic habitats,
human population density per area; Plasmodium spp.
For dichotomous outcomes, we extracted the number of partici-
pants experiencing each outcome and the number of participants
in each treatment arm. For count/rate data outcomes, we extracted
the number of outcomes in the treatment and control arms, and
the total person time at risk in each arm or the rate ratio, and a
measure of variance (for example, standard error). For continuous
outcomes, we extracted the mean and a measure of variance (stan-
dard deviation).
For cRCTs, we recorded the number of clusters randomized; num-
ber of clusters analyzed; measure of effect (such as risk ratio (RR),
odds ratio, or mean difference (MD)) with 95% confidence inter-
vals (CI) or standard deviations; number of participants; and the
intracluster correlation coefficient (ICC) value. Where trials re-
ported cluster-adjusted odds ratios, we converted these to RRs fol-
lowing themethodology stated in Section 12.5.4.4 of theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a).
For non-randomized studies, we extracted adjusted measures of
intervention effects that attempted to control for confounding.
Assessment of risk of bias in included studies
Two review authors (LC and JP) independently assessed the risk
of bias for each included cRCT using the Cochrane ‘Risk of bias’
tool and the five additional criteria listed in Section 16.3.2 of
the Cochrane Handbook for Systematic Reviews of Interventions that
relate specifically to cluster-randomized trials (Higgins 2011a;
Higgins 2011b). If identified, we would have assessed non-RCTs
and ITS trials for risk of bias using Cochrane EPOC’s ‘Risk of
bias’ tool. We resolved any discrepancies through discussion or by
consulting a third review author (PG). We classified judgements
of risk of bias as at low, high, or unclear risk of bias, and we used
summary graphs (‘Risk of bias’ summary and ‘Risk of bias’ graph)
to display results.
Due to the nature of the IRS application, blinding of participants
and study personnel was not possible. When assessing the risk of
performance bias, we considered that the primary outcomes of
malaria incidence and malaria parasite prevalence were unlikely to
be affected by participant knowledge of the intervention. There-
fore, we did not associate the lack of participant blinding with
a high risk of performance bias. When assessing the risk of de-
tection bias, we considered that measurements of incidence that
depended on self-reporting of fever may have been influenced by
the participants’ knowledge of the intervention. However, to meet
the inclusion criteria for this review, such cases required confirma-
tion of parasitaemia by blood smear microscopy or RDT, and the
results of these objective tests were considered unlikely to be in-
fluenced by knowledge of the intervention arm. Therefore, where
trials measured incidence using this method, we considered the
lack of blinding to introduce an unclear risk of bias; this is consis-
tent with the methods used by Pryce 2018.
Measures of treatment effect
We compared intervention and control data using RRs and for
count/rate data, we used rate ratios. We used adjusted measures of
effect to summarize treatment effect from non-randomized stud-
ies. We presented all results with their associated 95% CIs.
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Unit of analysis issues
For cRCTs, or cluster non-randomized trials, we extracted adjusted
measures of effect where possible. If included cRCTs had not ad-
justed for clustering in the analysis, we adjusted the data before
combining it. We adjusted data by multiplying the standard errors
by the square root of the design effect (Higgins 2011a), which was
determined by the ICC. If the trial did not report the ICC value,
we estimated the ICC value using a range of 0.01, 0.05, and 0.1.
When we estimated the ICC, we performed sensitivity analyses to
investigate the robustness of our analyses.
If we identified studies for inclusion that hadmultiple intervention
arms, we included data from these studies by either combining
treatment arms, or by splitting the control arm so that we only
included these participants in the meta-analysis once.
Dealing with missing data
In case of missing data, we applied available-case analysis, only
including data on the known results. The denominator was the
total number of participants who had data recorded for the spe-
cific outcome. For outcomes with no missing data, we planned to
perform analyses on an intention-to-treat basis. We included all
participants randomized to each arm in the analyses and analyzed
participants in the arm to which they were randomized.
Assessment of heterogeneity
We inspected forest plots for overlapping CIs and assessed sta-
tistical heterogeneity in each meta-analysis using the I² statistic
and Chi² statistic. We regarded heterogeneity as moderate if the
I² statistic was between 30% and 60%; substantial if it was be-
tween 59% and 90%; and considerable if it was between 75% and
100% (Deeks 2011). We regarded a Chi² test statistic with a P
≤ 0.10 indicative of statistically significant heterogeneity. We ex-
plored clinical and methodological heterogeneity through consid-
eration of the trial populations, methods, and interventions, and
by visualization of trial results.
Assessment of reporting biases
If there were 10 or more trials included in each meta-analysis, we
intended to investigate reporting biases (such as publication bias)
using funnel plots.We would have assessed funnel plot asymmetry
visually, and used formal tests for funnel plot asymmetry (Harbord
2006). If we detected asymmetry in any of these tests or by a visual
assessment, we would have explored the reasons for asymmetry.
As only six trials met the inclusion criteria, we did not investigate
reporting bias using a funnel plot. Instead, we compared the out-
comes reported against the trial protocols.
Data synthesis
We analyzed data using Review Manager 5 (Review Manager
2014). We used fixed-effect meta-analysis to combine data if het-
erogeneity was absent. For a meta-analysis of reported effect sizes,
we used a generalized inverse variance model. Where raw data
were used for a meta-analysis of RRs, we used a Mantel-Haenzel
model. For meta-analysis of RRs and odds ratios, if considerable
heterogeneity was present, we combined data using random-ef-
fects meta-analysis and reported a mean treatment effect. We de-
cided whether to use fixed-effect or random-effects models based
on the consideration of clinical and methodological heterogeneity
between trials, as described previously.
Certainty of the evidence
We assessed the certainty of the evidence using the GRADE ap-
proach (Guyatt 2011). We rated each important outcome as de-
scribed by Balshem 2011.
• High: we are very confident that the true effect lies close to
that of the estimate of the effect.
• Moderate: we are moderately confident in the effect
estimate. The true effect is likely to be close to the estimate of
the effect.
• Low: our confidence in the effect estimate is limited. The
true effect may be substantially different from the estimate of the
effect.
• Very low: we have very little confidence in the effect
estimate. The true effect is likely to be substantially different
from the estimate of effect.
RCTs started as high-certainty evidence but were downgraded if
there were valid reasons within the following five categories: risk
of bias, imprecision, inconsistency, indirectness, and publication
bias. Studies could also be upgraded if there was a large effect,
a dose-response effect, and if all plausible residual confounding
would reduce a demonstrated effect or would suggest a spurious
effect if no effect was observed (Balshem 2011). We summarized
our findings in Summary of findings for themain comparison and
Summary of findings 2.
Subgroup analysis and investigation of heterogeneity
To explore reasons for substantial heterogeneity, we performed the
following subgroup analysis.
• Use of ITNs, defined by individual use from the previous
night:
◦ high (50% or more);
◦ low (less than 50%).
We assessed differences between the subgroups using the Chi²
test, with a P value less than 0.1 indicating statistically significant
differences between subgroups.
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Sensitivity analysis
We planned to perform sensitivity analysis on the primary out-
come to see the effect of exclusion of trials at high risk of bias
(for allocation concealment and incomplete outcome data) on the
overall results. This was not required since all studies included
were at low or unclear risk of bias for those specific domains. If the
ICC value was estimated, we did sensitivity analyses to investigate
the impact of varying the ICC value on meta-analysis results.
R E S U L T S
Description of studies
We provided descriptions of the included and excluded studies
in the Characteristics of included studies and Characteristics of
excluded studies tables. Studies awaiting classification were de-
scribed in the Characteristics of studies awaiting classification ta-
ble.
Results of the search
We identified 998 reports through the electronic search. We re-
moved one duplicate and screened the remaining 997 abstracts
against the review’s inclusion criteria. Of these, we identified 36
unique reports for full-text screening (Figure 1).
Included studies
In total, six trials met the inclusion criteria, fromwhich eight com-
parisons were drawn. All six trials were cRCTs. Three trials (pro-
viding four comparisons) used a non-pyrethroid-like IRS through-
out the trial (Corbel 2012; Protopopoff 2018; West 2014), and
two trials (providing two comparisons) used a pyrethroid-like IRS
throughout (Keating 2011; Pinder 2015). One further trial used
a pyrethroid-like insecticide in the first study year, but replaced
it with a non-pyrethroid-like insecticide for the two subsequent
years, and therefore provided two different comparisons (Kafy
2017).
Comparison 1: IRS using non-pyrethroid-like insecticides
The four trials evaluating the effect of non-pyrethroid-like IRS
were conducted in sub-Saharan Africa; one in southern Benin (
Corbel 2012); one in south-eastern Sudan (Kafy 2017), and two in
north-west Tanzania (Protopopoff 2018; West 2014). The former
two regions experience seasonal transmission, while north-west
Tanzania has perennial transmission with two peak seasons. None
of the trials were conducted in epidemic areas.
Two trials evaluated the effect of adding IRS to ITNs using a two-
armed study design (Kafy 2017; West 2014). Two trials had four
arms.Corbel 2012 compareduniversal coverage of ITNs; universal
coverage of ITNs plus carbamate-treated plastic sheeting; targeted
ITNs (aiming only to cover pregnant women and children under
six years old); and targeted ITNs plus IRS. The latter two arms
provide the comparison for this review. Protopopoff 2018 used a
2 × 2 factorial design which compared standard LLINs; standard
LLINs plus IRS; pyrethroid-PBO nets; and pyrethroid-PBO nets
plus IRS.
Interventions
Coverage
IRS application coverage was described as 80% of households
in the study area (Corbel 2012), consistently above 80% (Kafy
2017), 94% in both IRS intervention arms (Protopopoff 2018),
and 89.3% to 92.1% (West 2014).
Insecticide
Two trials used a WP formulation of the carbamate bendiocarb,
at a dose of 400 mg/m² (Corbel 2012; West 2014), and in the
second year of another trial (Kafy 2017). Protopopoff 2018 used
Actellic 300CS (a commercial formulation of pirimiphos-methyl),
at a dosage of 1g/m².
Frequency
The frequency of spraying varied depending on the eco-epidemi-
ological conditions of each location. Two trials conducted two
rounds, four months apart, preceding each of two annual trans-
mission peaks (Kafy 2017; West 2014). Corbel 2012 repeated the
IRS cycle every eight months, and Protopopoff 2018 conducted
only one spraying round. Full characteristics of the interventions
are summarized in Table 4.
ITNs in intervention and control arms
In each of the trials, ITN distribution was equal between the inter-
vention and control arms. In two trials, the ITN distributed was
the deltamethrin-based PermaNet 2.0 (Corbel 2012; Kafy 2017),
while two trials involved distribution of the permethrin-based Ol-
yset Net (Protopopoff 2018; West 2014). In the two arms that
evaluated the efficacy of pyrethroid-PBO nets, Protopopoff 2018
usedOlyset Plus instead of OlysetNet. Ameasure of ITN coverage
and compliance for each study is summarized in Table 5.
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Cointerventions
The four trials did not report on any cointerventions.
Outcomes
Epidemiological
All four trials measured clinical outcomes in children only; one
in those under six years of age (Corbel 2012), one in children
aged one to 10 years of age (Kafy 2017) and two between six
months and 14 years (Protopopoff 2018; West 2014). Of the two
primary outcomes, malaria incidence was measured in two studies
(Corbel 2012; Kafy 2017), and malaria parasite prevalence was
measured in all four trials. Two trials also reported the prevalence of
childhood anaemia (Protopopoff 2018; West 2014). Protopopoff
2018 limited their analysis of anaemia to children aged six months
to four years.We extracted the nine-month postintervention cross-
sectional survey results only, as IRS was not conducted beyond
this time point, which acted as their main endpoint for assessing
the efficacy of IRS (Protopopoff 2018).
Entomological
Three trials reported estimated EIR, adult mosquito density, and
the sporozoite rate (Corbel 2012; Protopopoff 2018; West 2014).
Mosquito insecticide resistance
One trial additionally reported the prevalence in malaria vectors
of alleles associated with resistance to pyrethroids (1014F kdr) and
carbamates (G119S ace1) (Corbel 2012). Kafy 2017 reported the
level of phenotypic resistance to pyrethroids.
Comparison 2: IRS using pyrethroid-like insecticides
The three cRCTs evaluating pyrethroid-like IRS were all con-
ducted in sub-Saharan Africa; in the west lowlands of Eritrea
(Keating 2011), the upper river region of The Gambia (Pinder
2015), and in south-eastern Sudan (Kafy 2017). The regions each
experience seasonal transmission, and none were in epidemic ar-
eas.
Interventions
Coverage
IRS application coverage was described as consistently above 80%
(Kafy 2017), 84.8% (Keating 2011), and 83% to 86% (Pinder
2015).
Insecticide
Two trials used a wettable powder (WP) formulation of DDT, at a
dose of 1 g/m² to 2 g/m² (Keating 2011; Pinder 2015). One trial
used the pyrethroid deltamethrin at a dose of 25mg/m² in the first
study year (Kafy 2017).
Frequency
The frequency of spraying varied depending on the eco-epidemi-
ological conditions of each location. One trial conducted IRS
once per year to coincide with the start of the transmission sea-
son (Pinder 2015). One trial conducted two rounds, four months
apart, preceding each of two annual transmission peaks (Kafy
2017). One trial conducted only one spraying round (Keating
2011). Full characteristics of the interventions have been summa-
rized in Table 4.
ITNs in intervention and control arms
In each of the three trials, ITN distribution was equal between the
intervention and control arms. In one trial, the ITN distributed
was the deltamethrin-based PermaNet 2.0 (Kafy 2017), while one
trial involved distribution of the permethrin-based Olyset Net
(Pinder 2015). One trial did not distribute ITNs as the region
already had a high coverage; any LLIN, or ITN that had been
treated at least once in the last 11 months, was considered accept-
able when measuring net coverage in this study (Keating 2011). A
measure of ITN coverage and compliance for each study is sum-
marized in Table 5.
Cointerventions
One trial listed larval habitat management and continued case
management as cointerventions that were conducted in both inter-
vention and control arms during the study period (Keating 2011).
The remaining trials did not report on any cointerventions.
Outcomes
Epidemiological
Two trialsmeasured clinical outcomes in children only; one in chil-
dren aged one to 10 years of age (Kafy 2017), and one in children
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aged between six months and 14 years (Pinder 2015). The third
trial measured outcomes in participants of all ages (Keating 2011).
Of the two primary outcomes, two studies measured malaria in-
cidence (Kafy 2017; Pinder 2015), and all three trials measured
malaria parasite prevalence. One trial also reported the prevalence
of childhood anaemia (Pinder 2015). For malaria parasite preva-
lence and anaemia prevalence, Pinder 2015 reported separately ad-
justed effect estimates for both years of the study, 2010 and 2011,
so we included both estimates in the analysis separately.
Entomological
One trial reported the estimated EIR, sporozoite rate, and adult
mosquito density measured as the number of adult An gambiae s.l.
collected per trap per night (Pinder 2015).
Mosquito insecticide resistance
One trial measured the prevalence of alleles associated with
pyrethroid resistance only (Kafy 2017).
Excluded studies
We excluded 26 full-text articles for the following reasons:
• study design did not meet the inclusion criteria (18 full-text
articles);
• duplicate articles (eight full-text articles).
Full details are provided in the Characteristics of excluded studies
tables.
Studies awaiting classification
Four full-text articles describing three studies are currently re-
ported in the ‘Characteristics of studies awaiting classification’ ta-
ble. One is a stepped wedge design and the results presented are
not in a form that can be used in this analysis; we have requested
additional data from the study authors (Hamainza 2016). The
other two trials have been completed and we are awaiting publi-
cation of the results (Chaccour 2018; Deressa 2016).
Risk of bias in included studies
Trials overall were well designed with few concerns over risk of
bias (Figure 2). Details of the assessment are included in the ‘Risk
of bias’ table of the Characteristics of included studies table.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
We assessed five trials at low risk of bias for random sequence
generation and allocation concealment, as allocation was decided
using a computerized randomization algorithm (Corbel 2012;
Kafy 2017; Pinder 2015; Protopopoff 2018;West 2014).One trial
was at unclear risk of bias because the randomization procedure
was not described (Keating 2011).
Blinding
Due to the nature of the IRS application, blinding of participants
and study personnel was not possible. Participant and personnel
knowledge of intervention arm was not expected to have an influ-
ence on the outcomes included in this review.
One trial blinded microscopists (Pinder 2015). However, all six
trials measured prevalence using either a RDT or blood smear ex-
amination. As these tests are objective, all six trials were at low risk
of detection bias. Two trials that measured malaria incidence de-
pended on self-reporting of fever, and as such the detection of this
outcomemay have been influenced by the participants’ knowledge
of the intervention (Corbel 2012; Pinder 2015). However, both
cases confirmed parasitaemia using objective tests. Therefore, the
trials were at unclear risk of bias. The remaining trial used active
case detectionwith RDTs tomeasure incidence andwas, therefore,
considered at low risk of performance bias.
Incomplete outcome data
One trial reported a difference of more than 10% between the
intervention and control arms in person-days that were lost to
follow-up (Corbel 2012). This was judged at high risk of bias.
The remaining five trials were at low (Keating 2011; Pinder 2015;
Protopopoff 2018;West 2014) or unclear risk of bias (Kafy 2017).
Selective reporting
The trials reported on each of their intended outcomes as specified
in their registered protocols.
Other potential sources of bias
None of the trials were considered at risk of recruitment bias as the
study participants were randomly selected.One trial was at unclear
risk of baseline imbalance, as the baseline data for prevalence were
not reported (Keating 2011). No trials were at high or unclear risk
of bias from loss of clusters, incorrect analyses, or other biases.
Effects of interventions
See: Summary of findings for the main comparison ‘Summary
of findings’ table 1; Summary of findings 2 ‘Summary of findings’
table 2
Comparison 1: adding IRS using non-pyrethroid-like
insecticides to ITNs
See Summary of findings for the main comparison.
Malaria incidence
Two trials reported malaria incidence (Corbel 2012; Kafy 2017).
One trial reported a substantial benefit of IRS, while the other
reported a higher malaria incidence in the intervention arm. This
lack of consistency was reflected in the considerable heterogeneity
(I² = 84%). As there are only two trials, a subgroup analysis by
ITN usage would not be informative. Overall, the pooled analysis
gave a mean effect between the two results (rate ratio 0.93, 95%
CI 0.46 to 1.86; 2 cRCTs, 566 child-years; Analysis 1.1; very low-
certainty evidence).
The results from Kafy 2017 were noteworthy: the data from dif-
ferent years of the trial appeared in both Comparison 1 and Com-
parison 2. The first year had shown the addition of IRS using a
pyrethroid-like insecticide had no effect on malaria incidence (RR
1.00, 95% CI 0.36 to 2.78); in the second and third years, when
a non-pyrethroid-like insecticide was used for IRS, there was a
lower malaria incidence (RR 0.65, 95% CI 0.44 to 0.96).
Malaria parasite prevalence
All four trials assessed the effect on malaria parasite prevalence.
One trial provided two comparisons to the analysis, one compar-
ing standard ITNs plus IRS versus standard ITNs alone, and a sec-
ond comparing pyrethroid-PBO nets plus IRS versus pyrethroid-
PBO nets alone (Protopopoff 2018). In the comparison involving
standard ITNs, the addition of IRS was associated with a large
reduction in malaria parasite prevalence (RR 0.52, 95% CI 0.18
to 1.52). However, the effect was much less pronounced in the
comparison involving pyrethroid-PBO nets (RR 0.85, 95% CI
0.34 to 2.11). This may be explained by the improved effective-
ness of pyrethroid-PBO nets over standard ITNs seen in the study.
Even in the absence of IRS, the pyrethroid-PBO net arm had a
prevalence of 31%, compared to 55% in the standard ITN arm.
Across the included studies, the pooled analysis showed themalaria
parasite prevalence was lower when IRS was added (RR 0.67, 95%
CI 0.35 to 1.28; 4 cRCTs, 10,440 participants; Analysis 1.2; low-
certainty evidence). Most studies showed a benefit of IRS with
substantial reductions in prevalence, but one study again reported
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a higher prevalence in the intervention arm (Corbel 2012). This
lack of consistency is reflected in the considerable heterogeneity (I²
= 86%). We conducted a subgroup analysis by percentage of the
trial population sleeping under an ITN (Analysis 1.3). Two trials
were conducted with ITN use below 50% (Corbel 2012; West
2014), and two were conducted with ITN use of 50% or more
(Kafy 2017; Protopopoff 2018). This analysis did not explain the
heterogeneity.
The results from Kafy 2017 were noteworthy: the data from dif-
ferent years of the trial appeared in both Comparison 1 and Com-
parison 2. In the first year, following IRS implementation using
a pyrethroid-like insecticide, there was an increase in malaria par-
asite prevalence in the intervention arm (RR 1.96, 95% CI 0.86
to 4.46). However, in the second and third years, when a non-
pyrethroid-like insecticide was used for IRS, there was a large re-
duction in prevalence (RR 0.41, 95% CI 0.28 to 0.61).
Entomological inoculation rate
Three trials reported estimates of the EIR (Corbel 2012;
Protopopoff 2018; West 2014). Due to considerable differences
between trials in the way the EIR was defined, estimated, and in
the effect sizes reported, it was not possible to conduct a meta-
analysis. We presented the results of each trial in Table 6.
In summary, the EIR was lower when IRS was added in one of the
three trials. The results correlated with the reported epidemiolog-
ical outcomes in two of the three trials.
• Corbel 2012 reported a slightly lower mean value for the
number of infected bites per person per year when IRS was
added (7.3%, 95% CI 3.8 to 14.2) compared to the control arm
(9.4, 95% CI 5.1 to 17.1). This was concordant with the results
the trial report for epidemiological outcomes, where there was no
evidence of a lower malaria incidence or parasite prevalence in
the combined arm.
• In both comparisons of Protopopoff 2018, there was a
much lower mean EIR when IRS was added to nets. Similarly to
the above epidemiological outcomes, the lower EIR was more
marked in the comparison with the standard ITNs; whereas the
EIR in the ITN-only arm was much lower with the pyrethroid-
PBO net arm. We could not calculate CIs as the standard errors
were not given for the means.
• West 2014 reported no reduction in the mean number of
infected bites per household per month when IRS was added to
ITNs (1.1, 95% CI 0.4 to 2.8 in the ITN-only arm and 1.3,
95% CI 0.4 to 4.4 in the IRS plus ITNs arm). This finding was
inconsistent with the epidemiological outcomes, where the trial
reported a large reduction in both malaria parasite prevalence
and anaemia prevalence.
Sporozoite rate
Two trials reported the effect on the sporozoite rate (Protopopoff
2018; West 2014). Both defined this outcome as the proportion
of An gambiae s.l. caught from light traps with sporozoites.
• In both comparisons of Protopopoff 2018, the sporozoite
rate was lower when IRS was added. In the IRS plus standard
ITNs arm the proportion was 0.4% versus 2.8% in the standard
ITNs alone comparison. In the IRS plus pyrethroid-PBO net
arm the proportion was 0% versus 0.7% in the pyrethroid-PBO
net alone comparison. The trial did not report 95% CIs for these
measurements or an overall effect estimate.
• West 2014 reported a 28% reduction in the odds of a
mosquito being infected with sporozoites in the intervention arm
compared to the control arm, but the CI included no effect (OR
0.72, 95% CI 0.21 to 2.53).
Table 7 summarizes the characteristics and effects of all trials re-
porting the sporozoite rate included in this review.
Adult mosquito density
One trial measured adult mosquito density as a biting rate (Corbel
2012), and as the number of adult mosquitoes caught per trap
per night in both trials conducted in Tanzania (Protopopoff 2018;
West 2014). The differences in the reporting of these outcomes
precluded a quantitative synthesis. In summary, all three trials
reported a reduction in adult mosquito density when IRS was
added.
• Corbel 2012 reported a reduction of bites by 31% in the
intervention arm compared to the control arm, but the CIs were
wide and included no effect (rate ratio 0.69, 95% CI 0.38 to
1.25).
• In the IRS plus standard ITNs versus standard ITNs alone
comparison, Protopopoff 2018 reported a mean number of 2.37
vectors caught per night per household in the intervention arm
and 2.83 vectors per night per household in the control arm. In
the IRS plus pyrethroid-PBO nets the mean number was 1.85
versus 1.84 in the pyrethroid-PBO nets alone comparison. As
with the above EIR outcome, the trial did not report 95% CIs
for these measurements or an overall effect estimate.
• West 2014 reported a 77% reduction of adult mosquitoes
in the intervention arm compared to the control arm, but the
CIs included no effect (rate ratio 0.23, 95% CI 0.04 to 1.32).
Table 8 summarizes the characteristics and effects of all trials re-
porting adult mosquito density included in this review.
Anaemia prevalence
Two trials assessed the effect on anaemia prevalence. One trial
provided two comparisons to the analysis, one comparing stan-
dard ITNs plus IRS versus standard ITNs alone, and a second
comparing pyrethroid-PBO nets plus IRS versus pyrethroid-PBO
nets alone. Similarly to the previous outcomes, the introduction
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of IRS with a standard ITN was associated with a reduction in
the prevalence of anaemia compared to a standard ITN alone (RR
0.17, 95% CI 0.04 to 0.67), but the combination of IRS plus
pyrethroid-PBO net was not favourable to a pyrethroid-PBO net
alone (RR 1.18, 95% CI 0.09 to 15.08).
Across the included studies, the pooled analysis showed that the
prevalence of anaemia was lower when IRS was added to com-
munities using ITNs (RR 0.46, 95% CI 0.18 to 1.20; 2 cRCTs,
2026 participants; Analysis 1.4; low-certainty evidence), and the
meta-analysis showed moderate heterogeneity between trials (I² =
41%). As there are only two trials, a subgroup analysis by ITN
usage was not considered to be useful.
Insecticide resistance
Corbel 2012 reported the allelic frequency of 1014F kdr, a ge-
netic marker associated with resistance to pyrethroid insecticide in
mosquitoes. There was no difference detected in the frequency of
1014F kdr in the IRS plus ITNs arm (86%, 95% CI 80% to 92%)
compared to the ITN-only arm (86%, 95%CI 79% to 93%). The
trial did not report the individual frequency in each intervention
arm of G119S ace1, a genetic marker associated with resistance to
carbamate insecticides. However, it commented that the allele was
almost absent across the study area during the trial (less than 5%,
2123 participants).
Kafy 2017 reported that there was less phenotypic pyrethroid re-
sistance in the IRS plus ITNs arm, with 68% mosquito mortality
after exposure to deltamethrin (95% CI 60.0% to 76.0%) com-
pared to 56.1% mortality in the ITN-only arm (95% CI 47.1%
to 64.9%).
Comparison 2: adding IRS with pyrethroid-like
insecticides to ITNs
See Summary of findings 2.
Malaria incidence
The two trials that reported the effect on malaria incidence did
not detect an effect of IRS in communities that were using ITNs
(rate ratio 1.07, 95% CI 0.80 to 1.43; 2 cRCTs, 15,717 child-
years; Analysis 2.1; moderate-certainty evidence).
Malaria parasite prevalence
The three trials that reported the effect on malaria parasite preva-
lence did not detect an effect of IRS in communities that were
using ITNs, with no heterogeneity between the studies (RR 1.11,
95% CI 0.86 to 1.44; 10,820 participants; Analysis 2.2; moder-
ate-certainty evidence).
Entomological inoculation rate
One trial reported the effect on the estimated EIR (Pinder 2015).
The authors defined the estimated EIR as the mean number of
infected bites per person per transmission season. In the first year,
the trial reported a difference in the estimated EIR of 2.44 (95%
CI 0.69 to 6.39) without IRS and 1.08 (95% CI 0.16 to 4.02)
when IRS was added, but the CIs overlapped. The pattern in the
point estimates was the same in the second year, with an estimated
EIR of 1.45 (95% CI 0.15 to 5.69) without IRS and 0.29 (95%
CI 0.00 to 2.66) when IRS was added. While the point estimates
were not consistent with the human data, the wide CIs make
no inference possible. Table 6 summarizes the characteristics and
effects of all trials reporting the EIR included in this review.
Sporozoite rate
One trial reported the effect on the sporozoite rate (Pinder 2015).
The authors defined this as the proportion of An gambiae s.l.
caught using light traps, with sporozoites. The actual number of
infected mosquitoes detected was small (19 in both arms across
the two years). In the first year of assessment, 0.19% (4/2131) of
An gambiae s.l. were positive in the intervention arm, and 0.32%
(9/2829) were positive in the control arm. The risk of a mosquito
being infected with sporozoites was 41% lower in the interven-
tion arm compared to the control arm, but the analysis was un-
derpowered (RR 0.59, 95% CI 0.18 to 1.91). In the second year
of assessment, 0.65% (5/773) of An gambiae s.l. were positive in
the intervention arm and 0.09% (1/1131) in the control arm. The
risk of a mosquito being infected with sporozoites was more than
seven times higher in the intervention arm compared to the con-
trol arm, but again this was underpowered (RR 7.32, 95%CI 0.86
to 62.5). Table 7 summarizes the characteristics and effects of all
trials reporting the sporozoite rate included in this review.
Adult mosquito density
One trial reported the effect on adult mosquito density (Pinder
2015). The authors defined this outcome as the number of An
gambiae s.l. per trap per night. The trial used both light and exit
traps. There were no clear differences between the arms, and the
CIs were wide (2010 using light traps: MD -1.22, 95% CI -3.58
to 1.14; 2010 using exit traps: MD -0.13, 95% CI -0.54 to 0.28;
2011 using light traps: MD -0.69, 95% CI -2.15 to 0.77; and
2011 using exit traps: MD -0.40, 95% CI -1.05 to 0.25). Table
8 summarizes the characteristics and effects of all trials reporting
adult mosquito density included in this review.
Anaemia prevalence
The one trial that reported the prevalence of anaemia did not
detect an effect of IRS in communities that were using ITNs (RR
1.12, 95% CI 0.89 to 1.40; 4186 participants, 1 cRCT; Analysis
2.3; low-certainty evidence).
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Insecticide resistance
No trials reported level of insecticide resistance in such a way that
an effect size could be calculated. However, Kafy 2017 reported
that in the first year of the trial there was no difference inmosquito
deltamethrin mortality when IRS was added (65%, 95% CI 49%
to 81%) compared to the control arm (60%, 95% CI 44% to
76%).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Pyrethroid- like indoor residual spraying (IRS) + insecticide- treated nets (ITNs) versus ITNs alone for preventing malaria
Patient or population: people at risk of malaria
Setting: sub-Saharan Af rica (The Gambia, Sudan, Erit rea)
Intervention: combinat ion of IRS + ITNs - using an insect icide for IRS that has the same target site as the pyrethroids used in ITNs
Comparison: ITNs alone
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments:
The combination of IRS
and ITNs, when the in-
secticide used for IRS
has the same target
site as the pyrethroids
used in ITNsRisk with ITNs alone Risk with IRS + ITNs
Malaria incidence 215 cases per 1000
child-years
230 cases per 1000
child-years (172 to 307)
Rate ratio 1.07
(0.80 to 1.43)
15,717 child-years
(2 comparisons, 2
cRCTs)
⊕⊕⊕©
Moderatea
Probably had lit t le or
no ef fect on malaria
incidence compared to
ITNs alone
Malaria parasite preva-
lence
13.2 cases per 100 14.7 cases per 100 (11.
4 to 19.0)
RR 1.11 (0.86 to 1.44) 10,820 part icipants
(4 comparisons, 3
cRCTs)
⊕⊕⊕©
Moderatea
Probably had lit t le or no
ef fect on malaria par-
asite prevalence com-
pared to ITNs alone
EIR - - Mean EIR was lower
with IRS and ITNs than
ITNs alone
(2 comparisons, 1
cRCT)
⊕©©©
Very lowb,c
We do not know if there
was an ef fect on the
EIR compared to ITNs
alone.d
Anaemia prevalence
(haemoglobin < 8 g/ dL)
42.6 cases per 100 47.7 cases per 100 (37.
9 to 59.6)
RR 1.12
(0.89 to 1.40)
4186 part icipants
(2 comparisons, 1
cRCTs)
⊕⊕©©
Lowa,b
May have had lit t le or
no ef fect on anaemia
prevalence compared
to ITNs alone
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*The risk in the intervention arm (and its 95%CI) is based on the assumed risk in the comparison arm and the relative effect of the intervent ion (and its 95%CI). The assumed
risk of the comparison arm is calculated f rom the total number of events/ total number of part icipants in the control arms of the trials contribut ing to the meta-analysis
CI: conf idence interval; cRCT: cluster randomized controlled trial; IRS: indoor residual spraying; ITN: insect icide-treated net; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious imprecision: the CIs were wide and included both an increase and decrease in the outcome.
bDowngraded one level for serious indirectness: the evidence was provided f rom one trial only and it was not certain that the
reported ef fect would be seen in other malaria transmission sett ings.
cDowngraded two levels for very serious imprecision: the CIs for the mean EIR in the intervent ion arms were very wide,
including values that would represent both large increases and reduct ions f rom the mean EIR in the control arms.
dThe EIR was low in the control arm, ranging f rom 1.45 to 2.4 infect ious bites per person per transmission season. While the
point est imate of the EIR in the intervent ion arm was lower than the control, the CIs overlapped. The absolute dif f erence in
EIR was operat ionally unimportant.
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D I S C U S S I O N
Summary of main results
See Summary of findings for the main comparison and Summary
of findings 2.
Adding IRS using a non-pyrethroid-like insecticide to ITNs gave
mixed results and we could not explain why there were such differ-
ences between the trials. There was some indication of an added
effect on malaria and anaemia prevalence in some of the trials.
Adding IRS using a pyrethroid-like insecticide to ITNs did not
provide any improvement in malaria outcomes in the two trials to
date.
For both comparisons included in this review, entomological out-
comes were reported inconsistently, and qualitative comparisons
with the human malaria outcomes showed poor correlation in re-
lation to the presence or absence of an effect.
Certainty of the evidence
Details of the downgrading forGRADEare contained in the ‘Sum-
mary of findings’ tables. There was a large amount of qualitative
heterogeneity, with some studies reporting large effects, and some
studies reporting little or no effect in the primary outcomes. This
decreased the certainty of the evidence and raised doubts about
the generalizability to other settings.
Overall completeness and applicability of
evidence
Given the wide geographical variety of malaria endemicities, trans-
mission patterns, and insecticide resistance, we need to be cautious
with inferences to policy from the limited number of trials con-
ducted to date. The review included six trials, which were divided
into two main comparisons. With so few trials, showing variable
results, it was difficult to confidently draw conclusions about the
impact of adding IRS to ITNs. Applicability of vector control in-
terventions in different settings is always a concern. This is be-
cause only a few trials are conducted in very specific contexts. The
ecology, behaviour, and insecticide-resistance profiles of Anopheles
mosquitoes can vary massively between and within species. The
included studies in this review are all conducted in Sub-Saharan
Africa, between 2008 and 2016, with primary vectors all belong-
ing to the An gambiae s.I. species complex (Table 4). The effect of
combining IRS with ITNs in the trials reported here will not nec-
essarily apply to other target species in other settings, particularly
those which are more exophilic and exophagic (Okumu 2011).
The rationale for adding IRS to ITNs can be framed in three
contexts, and the applicability of the evidence to each of these is
discussed below.
First, where the maximum reduction of malaria that is feasibly
possible has already been achieved with one intervention, an incre-
mental impact may be expected by adding a second intervention
that also targets endophilic and endophagic mosquitoes (Okumu
2011). Though current WHO policy does not recommend the
addition of IRS where ITN compliance is low, instead favouring
the target of universal coverage of one core intervention, sugges-
tions have been made that rolling out IRS in an area with low ITN
compliance would compensate for the poor usage of ITNs (WHO
2014a). Our review presented findings from two trials conducted
in areas of low ITN compliance, with one inBenin and the other in
Tanzania, but the two trials had conflicting results (Corbel 2012;
West 2014).
A second rationale is that the addition of IRS may be useful in
an area where high pyrethroid resistance is causing ITNs to fail.
When the trials included in this review were conducted, only
pyrethroids were approved for use on ITNs, whereas four classes of
insecticides (including pyrethroids) could be used for IRS (WHO
2014b;WHO2014c;WHO2015a). By adding a non-pyrethroid-
like IRS to a pyrethroid ITN, one would expect the reduction
in efficacy due to pyrethroid resistance to be compensated for
(WHO 2012). Our review attempted to explore this by present-
ing separate analyses dependent on the target site of the insecti-
cides used for IRS. The rationale behind this was that if pyrethroid
resistance is causing ITNs to fail, introducing a pyrethroid-like
IRS will be unlikely to have a benefit. The included trials that
used pyrethroid-like insecticides followed this rationale, showing
no effect on epidemiological outcomes. In contrast, introducing
an non-pyrethroid-like IRS should improve malaria disease out-
comes. The findings of Kafy 2017 in particular support this con-
clusion, reporting reductions in malaria prevalence and incidence
only in the second and third years of the trial when the insecticide
used for IRS was changed to one with a non-pyrethroid target site.
Several trials using non-pyrethroid-like insecticides showed a clear
benefit of IRS with large reductions in prevalence, but one study
had higher malaria prevalence in the intervention arm (Corbel
2012). To further investigate this unexpected result, we re-exam-
ined the manuscript of Corbel 2012, which is reported in meticu-
lous detail. Though the trial was considered at high risk of attrition
bias, this was due to the number of theoretical child days lost to
follow up being higher in the intervention arm than in the control
arm. This potential bias would therefore be unlikely to overesti-
mate the malaria prevalence in the intervention arm. The trial was
conducted in an area of moderate allelic frequency of 1014F kdr,
associated with resistance to pyrethroids. There was high coverage
of IRS, and though ITN use during the trial was low, this was not
lower than another trial in the subgroup that reported a significant
effect (West 2014). This suggests their findings of no clear evidence
of benefit are valid, and not related to problems implementing the
intervention. As a result, there remains considerable unexplained
heterogeneity between trials for this comparison. More research
will be needed to understand this heterogeneity in order to predict
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when and where the combination of IRS and ITNs will have an
impact.
The findings of Protopopoff 2018 may help to indirectly assess
the relative importance of the above two concepts. In the trial, the
combination of IRS with pyrethroid-PBO nets provided no addi-
tional benefit compared to pyrethroid-PBO nets alone, suggesting
that the majority of the benefit seen when IRS was combined with
a standard ITN was due to the addition of an insecticide that is
effective against pyrethroid-resistant mosquitoes, rather than due
to the incremental impact of adding a second core intervention.
Third, one potential justification for combining a non-pyrethroid-
like IRS with ITNs is to restore susceptibility to pyrethroids in the
vector, or to prevent the emergence of resistance in the first place.
By this rationale, waiting to implement the combination of IRS
with ITNs until incremental impact is demonstrated over ITNs
alone may mean doing so far too late (Killeen 2018). While many
studies characterized insecticide resistance (either phenotypically,
genotypically, or both) at the start of the follow-up period, only
two trials continued to monitor the changes in insecticide resis-
tance postintervention rollout. The reporting of such outcomes
was heterogeneous, and we were unable to adequately explore the
effect that mass rollout of both core interventions would have on
insecticide resistance. While standardized methods of measuring
and reporting insecticide resistance would help to compare these
results between studies, it remains a matter of conjecture whether
a considerable change in resistance would be detected within the
period of a typical RCT.
Potential biases in the review process
We did not anticipate in our protocol separating the analyses by
whether the insecticide used for IRS had a pyrethroid-like or non-
pyrethroid-like target site (Choi 2017). However, because policy
makers and specialists in the field considered this to be critical
to decision making - to the extent that it would be unusual for
anyone to recommend pyrethroid-like insecticides for use in IRS
- we separated the analysis to be policy-relevant.
Agreements and disagreements with other
studies or reviews
There has beennoother systematic review conducted on this topic.
A narrative review published by theWHO included the studies by
Corbel 2012; Pinder 2015; and West 2014 (WHO 2014d). The
review suggested that West 2014 differed from the other studies,
showing a reduction in malaria epidemiological outcomes favour-
ing the intervention because the study area had low ITN usage.
However, our review includes new trials that show a reduction
in epidemiological outcomes even in areas with high ITN usage.
Whether or not the IRS was conducted using a pyrethroid-like
appears to be a better predictor for success or failure of the inter-
vention, although there remains some heterogeneity when a non-
pyrethroid-like insecticide is used. Where we have conducted sub-
group analysis to explore this heterogeneity, ITN usage was not
shown to be an effect modifier.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Four trials tested adding IRS using a non-pyrethroid-like insecti-
cide to ITNs, and gave mixed results. Three trials tested adding
indoor residual spraying (IRS) using a pyrethroid-like insecticide
to insecticide-treated nets (ITNs), and did not detect an improve-
ment in malaria outcomes. Thus, given the current evidence as-
sessed in this review, adding IRS in either set of circumstances is
difficult to justify on the basis that it will improve malaria con-
trol. The evidence from these trials was also insufficient to evalu-
ate whether adding IRS in communities using ITNs would be an
effective strategy to prevent pyrethroid resistance emerging.
Implications for research
In some trials assessing the combination of non-pyrethroid-like
IRS with ITNs, the effects were substantial, but this effect was ab-
sent in one trial. This creates uncertainty and needs further studies
to unravel these conflicting results. Researchers and policy makers
may wish to consider programme implementation using quasi-
experimental methods, such as stepped wedge designs. Improved
and standardized methods for measuring and reporting pyrethroid
resistance will help comparisons between studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Corbel 2012
Methods Study design: cRCT with 4 intervention arms
• LLIN targeted to pregnant women and children aged < 6 years (TLLIN)
• TLLIN + full coverage of carbamate IRS (TLLIN + IRS)
• ULLIN
• ULLIN + CTPS
Unit of allocation: clusters (villages)
Number of units: 28 villages randomized into 4 arms equally
Outcome assessment/surveillance type: 60 children randomly selected from each vil-
lage to participate in the study
• Active case detection for malaria episodes was done on the cohort of children
during 12 periods of 6 consecutive days at 6-weekly intervals. Thick blood films were
taken from every sick child.
• Cross-sectional surveys were done at each period of clinical monitoring on every
asymptomatic child who showed an axillary temperature < 37.5 °C. A thick film
sample was taken on the fourth day to ensure that asymptomatic children were not sick
in preceding days.
• From 14 January to 24 December 2009, mosquitoes were collected through 8
surveys of 2 consecutive days every 6 weeks. This collection occurred 2 weeks before
medical surveys. Sporozoite rate was detected using ELISA of heads and thoraces for P
falciparum CSP.
Length of follow-up: 18 months (23 June 2008 to 24 December 2009)
Adjustment for clustering: yes
Participants Number of participants: 3018 (429) TLLIN, 1996 (420) ULLIN, 2251 (415) ULLIN
+ CTPS, 2660 (413) TLLIN + IRS
Population characteristics:
• TLLIN arm coverage to pregnant women and children aged < 6 years
• Moderate level of pyrethroid resistance in malaria vectors (> 40% kdr allelic
frequency)
• Population size of 250-500 inhabitants with non-isolated habitations
• Absence of a local health centre
• Inclusion criteria for children were age (0-71 months) and their effective
domiciliation in these village
Withdrawal and loss to follow-up: in every arm, about 20% of the recordings were
not taken into account because of loss to follow-up (17%), death of children (1.5%),
and refusal (1.5%)
Interventions Relevant comparison for this review: TLLIN versus TLLIN + IRS
IRS:
Active ingredient and dosage: bendiocarb 400 mg/m²
Formulation: wettable powder
Frequency of spraying: every 8 months
Coverage: aimed for 80% coverage as per WHO recommendations
Buffer size between clusters: minimum 2 km between villages
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Corbel 2012 (Continued)
ITN:
Active ingredient and dosage: deltamethrin 55 mg (PermaNet 2.0)
Coverage: for TLLIN coverage, 1 LLIN was provided per sleeping unit of children < 6
years or pregnant women, or both, whereas 1 net was given to every sleeping unit for
ULLIN coverage. Overall, this corresponded to a mean of 1 LLIN every 4 people for
TLLIN and 1 net for every 2 people for ULLIN (census showed that themean number of
people per house was 4). Coverage was defined as the total number of hung nets relative
to the total number of sleeping units. Mean coverage was low: 38% in the control arm
and 45% in the intervention arm
Compliance: defined as proportion of children aged < 6 years sleeping under the net the
night preceding the visit. Mean compliance was low: 58% in the control arm and 45%
in the intervention arm
Control: ITN only as above
Cointerventions: none reported
Outcomes Incidence density rates of P falciparum clinical malaria in children aged < 6 years (defined
as malaria symptoms + a parasite density > 2000 parasites/µL)
Prevalence of asymptomatic infections in children aged < 6 years
Parasite density of asymptomatic infections in children aged < 6 years
EIR (as defined by the number of infected bites per person per year)
Prevalence of pyrethroid-resistant 1014F kdr allele and carbamate-resistant G119S ace1
allele in malaria vectors
Geometric mean of P falciparum parasites/µL
Location profile Study location: Ouidah-Kpomasse-Tori Bossito health district, southern Benin
Malaria endemicity: mesoendemic
EIR: control arm reported an annual mean of 9.4 infected bites/person/year (range 5.1-
17.1)
Population proximity/density: density/km²
TLLIN: 449
ULLIN: 462
ULLIN + CTPS: 577
TLLIN + IRS: 579
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An gambiae s.l. and An funestus s.l.
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not measured
Phenotypic resistance profile: not measured
Genotypic resistance profile:moderate kdr allelic frequency and virtually no ace1 allelic
frequency
Method of mosquito collection: adult female mosquitoes were caught using human
landing catches technique both indoors and outdoors at 4 sites per village from 10 p.m.
to 6 a.m. and for 2 consecutive nights per survey (that is, 16 person-nights per village
per survey). Independent staff regularly checked quality of the mosquito collections on
a randomly selected sample representing 12% of the total night-collection
Notes
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Corbel 2012 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “In each village, we randomly se-
lected 60 children aged < 6 years from
the census list of the inhabitants to par-
ticipate using computer-generated random
numbers. The allocation sequence and ran-
domization of the blocks and children were
prepared by the study statistician at IRD-
CREC.”
Allocation concealment (selection bias) Low risk Children and study investigators were not
blinded to treatment allocation but allo-
cation sequence and randomization of the
blocks and children were prepared by the
study statistician at IRD-CREC
Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk Participants and personnel were not
blinded to intervention.
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias
for prevalence as all cohort members had
their blood taken
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Unclear risk Participants and personnel were not
blinded to intervention.Unclear risk of bias
for incidence due to self-reporting of sick-
ness before confirmation bymicroscopy, an
objective assessment
Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias
for prevalence as all cohort members had
their blood taken
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow-up performed but over 10%
difference in children-days between the 2
arms: 5224 theoretical children-days miss-
ing in control arm, 6688 children-days
missing in intervention arm
Selective reporting (reporting bias) Low risk All children-days were analyzed. The study
protocol reported 1 each outcome as stated
in the clinical trials register (note: retrospec-
tively registered)
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Corbel 2012 (Continued)
Recruitment bias Low risk Cohort of childrenwere randomly selected.
Baseline imbalance Low risk Baseline data were displayed. No signifi-
cant differences at baseline between inter-
vention arms for incidence (P = 0.78). The
prevalence was significantly higher in the
TTLIN + IRS arm (P = 0.01). Entomolog-
ical outcomes were not provided at baseline
Loss of clusters Low risk No clusters were lost.
Incorrect analysis Low risk Adjustment for clustering was done.
Comparability with RCTs randomizing
participants
Low risk Because the intervention is expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
Kafy 2017
Methods Study design: cRCT with 2 intervention arms
Unit of allocation: clusters (villages)
Number of units: 26 villages randomized into 2 arms equally. Each cluster consisting
of ≥ 500 households
Outcome assessment/surveillance type: 60 children randomly selected from each vil-
lage to participate in the study
• Active case detection for malaria episodes was done on the cohort of children aged
0.5-10 years weekly during the peak of the malaria season (September to November)
and fortnightly during the remainder of the year, for a total of 30 annual visits. during
12 periods of 6 consecutive days at 6-weekly intervals. Malaria was confirmed by RDT
(SD BIOLINE-Malaria Ag P.f/P.v.; Standard Diagnostics, Inc.), or microscopy, or both.
• Prevalence of infection was measured once each year, during September to
October. Cohort of children were tested for P falciparum infection using RDTs (SD
BIOLINE-Malaria Ag P.f/P.v.; Standard Diagnostics, Inc.) irrespective of symptoms.
Length of follow-up: 1 June 2012 to 31 May 2015
Adjustment for clustering: yes
Participants Number of participants: total population in study area in 2011 was 139,566. Over the
3-year study period, 7529 children were recruited who were followed up cumulatively
for 17,284 person-years
Population characteristics: a baseline household census estimated that the area com-
prised approximately 119,000 households in 197 villages with 600,000 inhabitants who
were predominantly dependent on rain-fed agriculture. Mean age of cohort children
were similar across all study arms (about 5-6 years old)
Withdrawal and loss to follow-up: not reported
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Kafy 2017 (Continued)
Interventions Comparison: IRS + ITN versus ITN alone
IRS:
Active ingredient, dosage, and formulation: deltamethrin 25 mg/m² in 2012 (formula-
tion not reported, Chema Industries), bendiocarb 200 mg/m² in 2013 and 2014 (Ficam
80%, wettable powder, Bayer)
Frequency of spraying: IRS was conducted in August and late December of each year
Coverage: 99% in 2012, 82% in 2013, and 83% in 2014
Buffer size between clusters: minimum 3 km between the edges of adjoining clusters
ITN:
Active ingredient and dosage: deltamethrin 55 mg (PermaNet 2.0)
Coverage: an annual intervention assessment survey showed that household net owner-
ship was 99.6% in 2012, 82.1% in 2013, and 98.6% in 2014
Compliance: defined as the proportion of affirmative responses to the question “Did this
child sleep under an LLIN last night?” In 2012, this was 79% in both arms. In 2013, it
was 74% in the LLIN-only arm and 75% in the LLIN + IRS arm. In 2014, it was 82%
in both study arms
Control: ITN only as above
Cointerventions: none reported
Outcomes • Incidence of malaria in children aged 0.5-10 years
• Prevalence of malaria infection in children aged 0.5-10 years
• Deltamethrin susceptibility using WHO discriminating dose tests
• Prevalence of pyrethroid-resistant 1014F kdr allele
• Cost and cost-effectiveness
Location profile Study location:Galabat, south-eastern Sudan, located around 80 km fromGedarif town
and borders Ethiopia
Malaria endemicity: highly seasonal
EIR: not reported
Population proximity/density: not reported
Plasmodium spp: P falciparum accounts for 95% of the malaria burden
Vector profile Primary (and secondary) vector species: An arabiensis
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: mean percentage mortality in the LLIN arm (65.0%,
95% CI 44.6% to 85.3%) was not significantly different from that of the LLIN + IRS
arm (60%, 95% CI 38.2% to 82.2%) during 2012 (t = 0.425; degrees of freedom 9; P
= 0.68)
Genotypic resistance profile: Vgsc-1014F allelic frequency was around 60% in
mosquitoes sampled from both study arms in 2012
Method of mosquito collection: Anopheles larvae and pupae were collected annually
during the rainy season. Adults were collected using pyrethrum spray catches. 24 An
arabiensis females per cluster were selected at random for Vgsc-1014F genotyping to
estimate a cluster-specific resistance marker frequency
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters were randomly allocated using
a restricted randomization computerized
procedure. Balance criteria were prevalence
of P falciparum infection, ITN use, kdr fre-
quency in An arabiensis and cluster popu-
lation size. Out of 200,000 random alloca-
tions, 8000 yielded balance between study
arms on these criteria, from which 1 se-
quence was randomly selected
Allocation concealment (selection bias) Low risk The 26 clusters in Gedarif, Sudan were ran-
domized to receive LLIN + IRS or LLINs
alone, using restricted randomization to
ensure balance between study arms
Balance criteria were: prevalence of P fal-
ciparum infection and ITN use as deter-
mined in a baseline survey, kdr frequency
in An arabiensis from a survey of mosquito
collections carried out in each cluster, and
cluster population size. Out of 200,000
random allocations of the 26 clusters, 8000
yielded balance between study arms on
these criteria. Of these, 1 allocation was
randomly chosen, after verifying that the
imposed restriction did not introduce un-
due dependence between clusters
Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias for
both incidence and prevalence. RDTs and
microscopy were used to confirm malaria
infection
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias for
both incidence and prevalence. RDTs and
microscopy were used to confirm malaria
infection
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias for
both incidence and prevalence. RDTs and
microscopy were used to confirm malaria
infection
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Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk Participants and personnel were not
blinded to intervention. Low risk of bias for
both incidence and prevalence. RDTs and
microscopy were used to confirm malaria
infection
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No report of withdrawals.
Selective reporting (reporting bias) Low risk All children-days were analyzed. The study
protocol reports 1 each outcome as stated in
the clinical trials register (note: retrospec-
tively registered)
Recruitment bias Low risk Cohort of children were randomly selected
Baseline imbalance Low risk Although baseline information was not
available, key effect modifiers such as age
and LLIN usage were measured during the
study and there were no significant differ-
ences
Loss of clusters Low risk No clusters were lost.
Incorrect analysis Low risk Adjustment for clustering was done.
Comparability with RCTs randomizing
participants
Low risk Because the intervention is expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
Keating 2011
Methods Study design: cRCT with 2 intervention arms
Unit of allocation: clusters (villages)
Number of units: 58 randomized villages in each arm
Outcome assessment/surveillance type: 15 houses within each village were randomly
selected to serve as ultimate sampling units, giving 870 houses in each arm of the study.
Household residents were given a questionnaire and took a RDT (Carestart) for malaria
infection. Positive tests were confirmed by blood smear microscopy
Length of follow-up: 3-4 months post spraying (6-15 October 2009)
Adjustment for clustering: yes
Participants Number of participants: 7273 resided in participating houses. In the paper, 5508 total
from Table 2 but 5502 stated in results
Population characteristics: the distribution of participants living in houses located
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in treatment and control villages was similar on sex, age, employment status of the
respondent, and education level
Withdrawal and loss to follow-up: test refusal rates differed between treatment (8.5%)
and control (12.7%) arms (P < 0.05)
Interventions Comparison: IRS + ITN versus ITN alone
IRS:
Active ingredient and dosage: DDT 1-2 g/m²
Formulation: wettable powder
Frequency of spraying: once, June-July 2009
Coverage: minimum 80% target (84.8% of households sampled sprayed within 12
months)
Buffer size between clusters: > 5 km between intervention and control villages. in 2
instances whereby a treatment village was too close (< 5 km) to a control village, the
closest village > 5 km was selected into the control arm
ITN: any ITN that was treated at least once in last 11 months, or was an LLIN
Coverage: measured as people living in household owning ≥ 1 ITN: 75.8% (range 74.
2% to 77.4%)
Compliance: measured as individuals using ITN in the previous night: 50.7% (range
48.6% to 52.8%)
Control: ITN only as above
Coverage: measured as people living in household owning ≥ 1 ITN: 72.0% (range 70.
2% to 73.7%)
Compliance: measured as people using ITN in the previous night: 46.2% (range 43.9%
to 48.6%)
Cointerventions: larval habitat management and continued case management
Outcomes Malaria prevalence: parasite infection and febrile illness data from all household residents
> 1 month old requiring a positive RDT (Carestart) and a positive thick blood film
Location profile Study location: Gash Barka, West lowlands of Eritrea, mostly rural and agricultural.
Altitudes were 1500-3000 m above sea level. 30% of the country’s population lived here.
Approximately 200 mm per year precipitation. Temperatures were extremely hot and
dry climatic conditions with seasonal precipitation, concentrated in the summer months
Malaria endemicity: season with peak transmission occurring September-November.
Smaller malaria season March-April
EIR: study references an estimated annual range of 0-70.6 (Shililu 2004).
Population proximity/density: not reported
Plasmodium spp: P falciparum with rare reports of P vivax
Vector profile Primary (and secondary) vector species: An arabiensis and An gambiae s.s.
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: not reported
Genotypic resistance profile: not reported
Method of mosquito collection: no entomological data collected
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Fifty-eight (58) villages within
Gash Barka were randomly…”
Comment: however randomization proce-
dure was not described.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk Outcome not reported.
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk Participants and personnel were not
blinded to the intervention status; however,
the outcome would not be affected by this
knowledge
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Low risk Outcome not reported.
Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk Outcome assessors were not blinded to
the intervention status; however, the out-
come was measured using an objective tool
(Carestart RDT) and would not be affected
by this knowledge
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only one time point used, inapplicable
Selective reporting (reporting bias) Low risk The study only intended to report the re-
lationship between IRS and parasite preva-
lence and this outcome was provided.
Numbers appeared correct, assumed typo-
graphical error in table 2, should read 5502
Recruitment bias Low risk Households for survey were randomly se-
lected.
Baseline imbalance Unclear risk Baseline data were not displayed but due
to randomization this should be accounted
for
Loss of clusters Low risk No mention of lost clusters.
Incorrect analysis Low risk Adjustment for clustering was done.
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Comparability with RCTs randomizing
participants
Low risk Because the intervention is expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
Pinder 2015
Methods Study design: cRCT with 2 intervention arms
Unit of allocation: clusters of villages, each cluster consisted of 1-3 neighbouring villages
(97 villages in total)
Number of units: 35 randomized clusters in each arm. A subset of 16 clusters per arm
was used for entomological assessment
Outcome assessment/surveillance type:
• Children in the study villages aged 6 months to 14 years were sampled according
to cluster size and enrolled into a study cohort
• Incidence rates monitored through passive case detection at local health facilities
• Prevalence and parasite rates were measured at the end of each transmission season
• Mosquito density was assessed using light traps and exit traps in 6 sentinel sites in
each of 32 clusters, 1 night per month
Length of follow-up: 2 years (2010-2011), 2 transmission seasons (June-December
2010 and 2011)
Adjustment for clustering: cluster adjustedmeasureswere presented for some outcomes.
Participants Number of participants: control: 3949 enrolled children, intervention: 3896
Population characteristics: cohort of children aged < 14 years. Ethnic origin varied
with more Mandinka and lower Fula people in the LLIN arm than in the IRS + LLIN
arm
Withdrawal and loss to follow-up: separate analysis was done per survey, each time a
survey was done, cohorts would be replenished
Interventions Comparison: IRS + ITN versus ITN alone
IRS:
Active ingredient and dosage: DDT target dose 2 g/m² (2010 mean: 1.69 g/m², 2011:
3.27 g/m²)
Formulation: 75% wettable powder
Frequency of spraying: once per transmission season (15-28 July 2010, and 20 July to 9
August 2011)
Coverage: per cluster in 2010 (%): 86 (range 82.84-90.16); per cluster in 2011 (%): 83
(range 79.27-86.28)
Buffer size between clusters: > 2 km
ITN:
Active ingredient and dosage: permethrin 2% w/w (Olyset Net)
Coverage: nets were provided to cover all sleeping spaces as determined by a baseline
survey. 59% coverage in June 2010. 89% coverage in January 2011. 93% in January
2012
Compliance: not reported
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Control: ITN only as above
Coverage: 2010: 62%; 2011: 92%; 2012: 96%.
Compliance: not reported
Cointerventions: none reported
Outcomes Primary:
Incidence of clinical malaria assessed by passive case detection
Number of An gambiae s.l. collected per light trap per night
Secondary:
Haemoglobin concentration
Proportion of children with moderate anaemia (< 80 g/L) and severe anaemia (< 50 g/L)
Presence of malaria parasites
Parasite density
Proportion of children with high parasitaemia (> 5000 parasites/µL)
Prevalence of children with enlarged spleens measured at the end of the transmission
season each year
Sporozoite rate estimates in trapped mosquitoes
Estimated EIR (mean number of infective mosquito bites per person per season)
Location profile Study location: Upper River Region of The Gambia, > 110 children aged 6 months to
14 years on 1 June 2010
Malaria endemicity: moderate seasonal malaria transmission
EIR: estimated seasonal mean from the control arm of the study measured 2.44 (range
0.69-6.39) in the first year and 0.29 (0.003-2.66) in the second year
Population proximity/density: not reported
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An gambiae s.l.
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: not reported
Genotypic resistance profile: not reported
Method of mosquito collection: light and exit traps indoors in 6 rooms in 6 different
randomly selected compounds per cluster, 1 night per month
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Villages were randomly assigned using a
computerized algorithm
Allocation concealment (selection bias) Low risk Villages were randomly assigned using a
computerized algorithm
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Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk Participants and personnel were not
blinded to intervention.
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk For prevalence, risk of bias is low as every
participant had their blood taken
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Unclear risk Unclear risk of bias for incidence due to
self-reporting of sickness before confirma-
tionbymicroscopy, an objective assessment
Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk For prevalence, risk of bias was low as ev-
ery participant had their blood taken. Ob-
server bias was reducedwhere feasible. Slide
microscopists and their supervisors were
blinded to the identity and intervention
status of the participants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Incomplete outcome data were minimal
and similar between intervention arms. At-
trition between 2010 and 2011 accounted
for by topping up cohort with newborn
children (312 in LLIN + IRS arm; 324 in
LLIN-only arm)
Selective reporting (reporting bias) Low risk The study protocol reported on each out-
come as stated in the clinical trials register
(note: retrospectively registered)
Recruitment bias Low risk Cohort of childrenwere randomly selected.
Baseline imbalance Low risk Baseline data were displayed and similar.
Loss of clusters Low risk No clusters were lost.
Incorrect analysis Low risk Adjustment for clustering was done.
Comparability with RCTs randomizing
participants
Low risk Because the intervention was expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
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Methods Study design: cRCT with 4 intervention arms using a 2 × 2 factorial design
• arm 1: standard LLIN (Olyset Net)
• arm 2: standard LLIN (Olyset Net) + IRS
• arm 3: pyrethroid net + synergist PBO (Olyset Plus)
• arm 4: pyrethroid net + synergist PBO (Olyset Plus) + IRS
Therefore, there were 2 comparisons for this review: arm 1 versus arm 2, and arm
3 versus arm 4
Unit of allocation: clusters comprised from 40 villages
Number of units: 48 clusters randomized into 4 arms equally
Outcome assessment/surveillance type: cross-sectional surveys of children aged 0.5-
14 years were done to determine the prevalence of Plasmodium spp infection. The main
endpoint for assessment of the IRS was 9 months postintervention. Up to 3 children
from 55 households with eligible participants per cluster were randomly selected for each
survey
Length of follow-up: originally planned for 18 months (1 January 2015 to 30 June
2016) but was subsequently extended to 24 months (1 January 2014 to 31 December
2016)
Adjustment for clustering: yes
Participants Number of participants: at the primary endpoint for assessment of the IRS, the number
of children recruited were 933 in arm 1, 877 in arm 2, 883 in arm 3, and 969 in arm 4
Population characteristics:
• total population in core and buffer areas ranged from 31,138 to 38,081
• total population in the core area of the clusters between 14,845 and 16,358
Withdrawal and loss to follow-up: a fresh cohort was recruited for each cross-sectional
survey and ITT analysis was conducted
Interventions IRS:
Active ingredient and dosage: pirimiphos-methyl at the recommended dosage 1 g/m²
Formulation: 30% capsule suspension (Actellic 300CS)
Frequency of spraying: once in February 2015
Coverage: per cluster (%): 94% (95% CI 92% to 96%) in arm 2 and 94% (95% CI
87% to 97%) in arm 4
Buffer size between clusters: minimum outer buffer zone of 300 m. Only the inner core
area was used for the measurement of study outcomes
ITN:
Active ingredient and dosage: permethrin 2% w/w (Olyset Net) and permethrin 2%
(Olyset Plus) and PBO 1% w/w
Coverage: 9 months postintervention, coverage defined as household owning ≥ 1 LLIN
(study LLIN or any other LLIN) was 98% (95% CI 96% to 99%) in arm 2 and 98%
(95% CI 95% to 99%) in arm 4
Compliance: at 9 months postintervention, compliance defined as residents declaring
to use an LLIN the previous night (study LLIN or any other LLIN) was 76% (95% CI
70% to 80%) in arm 2 and 77% (95% CI 70% to 83%) in arm 4
Control: ITN only as above
Coverage: at 9 months postintervention, coverage defined as household owning ≥ 1
LLIN (study LLIN or any other LLIN) was 97% (95% CI 93% to 99%) in arm 1 and
98% (95% CI 97% to 99%) in arm 3
Compliance: at 9 months postintervention, compliance defined as residents declaring to
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use a LLIN the previous night (study LLIN or any other LLIN) was 80% (95% CI 75%
to 85%) in arm 1 and 78% (95% CI 73% to 82%) in arm 3
Cointerventions: none reported
Outcomes • Prevalence of Plasmodium spp infection
• Proportion of children with moderate-to-severe anaemia (defined as haemoglobin
< 8 g/dL)
• EIR defined as the mean number of infective mosquito bites per household per
month
• Adult mosquito density per night per household
Location profile Study location: Northwest Tanzania, Muleba Distract, Kagera Region, the study area
comprised 29,365 households and a population of 135,900 people
Malaria endemicity: perennial with peaks after the rainy season. Rainfall occurs in 2
seasons: the “short rains” in October-December (mean monthly rainfall 160 mm) and
the “long rains” in March-May (mean monthly rainfall 300 mm)
EIR: not measured at baseline
Population proximity/density: not reported
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An gambiae s.s. (An arabiensis and An funestus)
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not reported
Phenotypic resistanceprofile:An gambiae s.l.hadhigh levels of resistance to pyrethroids.
Genotypic resistance profile: theVgsc gene mutation was found in all tested An gambiae
s.l. with co-occurrence of Vgsc-1014F and Vgsc-1014S in 22 (9%) of 234 An gambiae s.
l. mosquitoes. No mutation was found in the 247 An arabiensis tested.
Method of mosquito collection: mosquito surveillance was done fromMarch 2015 to
December 2016, in each cluster by a project field assistant for 1 night per month in 7
randomly selected houses per cluster using CDCMiniature Light TrapModel 512 (John
W Hock Company, USA)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk During each survey, we randomly sampled
55householdswith children aged6months
to 14 years from the core area of each cluster
using the census lists
Allocation concealment (selection bias) Low risk The inhabitants of each cluster to the type
of LLINs received. The 2 types of nets were
of similar colour and shape, and only dis-
tinguishable by label codes and coloured
thread inserted during manufacture. Addi-
tionally, field staff who took blood samples
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in the cross-sectional surveys were masked
to the study arms the clusters were assigned
to
It was not possible to blind either the in-
vestigators or the participants to the treat-
ment allocation of IRS but we do not feel
this would impact the outcome
Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk This outcome was not measured.
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk Field staff who took blood samples in the
cross-sectional surveys were masked to the
study arms the clusters were assigned to
It was not possible to mask either the inves-
tigators who assessed the blood samples or
the participants to the treatment allocation
of IRS but we do not consider this would
impact the outcome which was assessed by
RDT (an objective test)
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Low risk This outcome was not measured.
Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk Field staff who took blood samples in the
cross-sectional surveys were masked to the
study arms the clusters were assigned to
It was not possible to blind either the in-
vestigators or the participants to the treat-
ment allocation of IRS but we do not feel
this would impact the outcome which was
assessed by RDT (an objective test)
Incomplete outcome data (attrition bias)
All outcomes
Low risk A new cohort of children was used for each
cross-sectional survey
Selective reporting (reporting bias) Low risk The study protocol reported each outcome
as stated in the clinical trials register (note:
retrospectively registered)
Recruitment bias Low risk Cohort of childrenwere randomly selected.
Baseline imbalance Low risk Baseline data was displayed. No significant
differences at baseline for outcomes the
study assessed
Loss of clusters Low risk No clusters were lost.
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Incorrect analysis Low risk Adjustment for clustering was done.
Comparability with RCTs randomizing
participants
Low risk Because the intervention is expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
West 2014
Methods Study design: cRCT with 2 intervention arms
Unit of allocation: clusters (villages)
Number of units: 25 randomized villages in each arm. A subset of 20 villages per arm
was used for entomological assessment
Outcome assessment/surveillance type: see below in ‘Outcomes’ section
Length of follow-up: 3 postintervention cross-sectional household surveys were under-
taken in 2012. Survey A (23 February to 31 March) was after the short rainy season
and 2 months after the first spray round. Survey B (25 June to 31 July) was after the
long rainy season, 6 months after the first spray round, and 2 months after the second
spray round. Survey C (25 October to 4 December) was 6 months after the second spray
round and 10 months after the first. Baseline surveys were conducted in 2011 during
the same periods as surveys A and B
Adjustment for clustering: yes
Participants Number of participants: for each of the survey, a different number of participants were
used in each cohort
• Survey A: 2192 children in control arm, 2348 in intervention arm
• Survey B: 2045 children in control arm, 2207 in intervention arm
• Survey C: 2101 children in control arm, 2303 in intervention arm
Population characteristics: cohort of children aged 0.5-14 years, villages had to be
sprayed with IRS in the baseline year
Withdrawal and loss to follow-up: 82.2% to 84.4% of intervention participants tested
in each survey. 78.3% to 80.8% of control participants tested
Interventions IRS:
Active ingredient and dosage: bendiocarb 400 mg/m²
Formulation: 80% wettable powder
Frequency of spraying: 2 rounds of spraying (December 2011 to January 2012) and
(April 2012 to May 2012), timed to precede the peak in malaria cases that normally
occurs at the end of each rainy season
Coverage: survey A: 92.1% (88.4% to 94.7%) (1215); survey B: 89.5% (84.0% to 93.
2%) (1138); survey C: 89.3% (83.6% to 93.2%) (1209)
Buffer size between clusters: each village was divided into a core surveillance area consist-
ing of ≥ 200 houses and approximately 1 km radius, where the surveys were conducted,
and an outer buffer zone of approximately 1 km width which also received treatment
but in which no outcome monitoring was done
ITN:
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Active ingredient and dosage: permethrin 2% w/w (Olyset Net)
Coverage measured as % of households with ≥ 1 ITN per sleeping space: survey A: 57.
2 (range 53.6-60.7) (1215); survey B: 57.4 (range 54.0-60.9) (1142); survey C: 56.8
(range 51.7-61.8) (1211)
Coverage measured as % of households with ≥ 1 ITN: survey A: 89.0 (range 87.1-90.
6) (1216); survey B: 88.2 (range 85.7-90.3) (1142); survey C: 83.8 (range 79.9-87.1)
(1211)
Compliance measured as % of study children that reported sleeping under an ITN the
night previous to the survey:
survey A: 53.0 (range 47.5-58.3) (2349); survey B: 44.1 (range 39.2-49.2) (2207); survey
C: 36.1 (range 31.0-41.5) (2303)
Control: ITN only as above
Coverage measured as % of households with ≥ 1 ITN per sleeping space: survey A: 52.
2 (range 47.8-56.5) (1178); survey B: 51.6 (range 47.0-56.0) (1094); survey C: 52.8
(range 47.6-58.0) (1168)
Coverage measured as % of households with ≥ 1 ITN: survey A: 85.8 (range 83.7-87.
7) (1177); survey B: 82.5 (range 78.7-85.7) (1096); survey C: 78.2 (range 74.3-81.6)
(1170)
Compliance measured as % of study children that reported sleeping under an ITN the
night previous to the survey: survey A: 46.6 (range 41.7-51.6) (2193); survey B: 40.7
(range 34.7-47.0) (2045); survey C: 36.0 (range 29.8-42.6) (2101)
Cointerventions: none reported
Outcomes P falciparum parasite rate in children aged 0.5-14 years, 80 households in each cluster.
Up to 3 children per household selected. Aimed for a mean of 80 children per cluster.
Tested with RDT (Carestart (Pan) Malaria, DiaSys)
Anaemia in children aged < 5 years
Mean haemoglobin in children aged < 5 years. Tested with HemoCue Hb 201+ (Ak-
tiebolaget Leo Diagnostics)
EIR: 20/25 clusters per arm were monitored for 1 night each month from April 2011 to
December 2012. 8 randomly selected houses in each cluster
Sporozoite rate
Location profile Study location: Northwest Tanzania, Muleba Distract, Kagera Region, the study area
included 68,108 households at an altitude of 1100-1600 m above sea level. Rainfall
occurred in 2 seasons: the ‘short rains’ in October-December (mean monthly rainfall
160 mm) and the ‘long rains’ in March-May (mean monthly rainfall 300 mm)
Malaria endemicity: perennial with peaks after the rainy season
EIR: baseline characteristics measured by the study reported a mean per month in the
control arm of 1.1 (range 0.4-2.8) and 1.3 (range 0.4-4.4) in the intervention arm
Population proximity/density: not reported
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An gambiae s.s. and An arabiensis
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/en-
dophilic, exophagic/endophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: resistance to pyrethroids in An gambiae s.s.
Genotypic resistance profile: not reported
Method of mosquito collection: CDC light traps indoors
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Twenty-five clusters were ran-
domly allocated to receive IRS…”
Comment: 200,000 random allocations
were generated. 1 allocation was randomly
selected from the list of these with no intr-
acluster dependence on key variables
Allocation concealment (selection bias) Low risk Allocation concealment was a low risk of
bias considering the computer-randomized
allocation
Blinding of participants and personnel
(performance bias)
Incidence of malaria
Low risk Outcome not reported.
Blinding of participants and personnel
(performance bias)
Prevalence of malaria
Low risk Participants could not be blinded to the
control and intervention. However, the
outcomes recorded were objective and at
low risk of being affected by intervention
arm knowledge
Blinding of outcome assessment (detection
bias)
Incidence of malaria
Low risk Outcome not reported.
Blinding of outcome assessment (detection
bias)
Prevalence of malaria
Low risk Outcome assessors were not blinded to
the control and intervention. However, the
outcomes recorded were objective mea-
surements (using RDTs, and standardized
mosquito traps)
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT was done, balanced numbers in both
arms.
Selective reporting (reporting bias) Low risk Outcomes reported match those in the
registered protocol, but children aged 6
months to 10 years rather than 14 years was
reported in the trial protocol
Recruitment bias Low risk Cohort of childrenwere randomly selected.
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West 2014 (Continued)
Baseline imbalance Low risk Baseline characteristics were presented for
both study arms and showed similarity
across key characteristics
Loss of clusters Low risk 1 cluster was assigned the wrong interven-
tion and then dropped. Sensitivity analysis
was done to show this did not impact the
outcome
Incorrect analysis Low risk Adjustment for clustering was done.
Comparability with RCTs randomizing
participants
Low risk Because the intervention is expected to
have community level impact as well as in-
dividual impact, cRCTs are the most ap-
propriate study design to capture this
Other bias Low risk No other biases.
Abbreviations: Anopheles arabiensis: An arabiensis; An funestus: Anopheles funestus;An gambiae: Anopheles gambiae; cRCT: cluster ran-
domized controlled trial; CSP: circumsporozoite protein; CTPS: carbamate-treated plastic sheeting; DDT: dichloro-diphenyl-
trichlorethane; EIR: entomological inoculation rate; ELISA: enzyme-linked immunosorbent assay; IRD-CREC: Institut de
Recherche pour le Développement Centre de Recherches Entomologiques de Cotonou; IRS: indoor residual spraying; ITN: in-
secticide-treated net; ITT: intention to treat; LLIN: long-lasting insecticidal mosquito net; P falciparum:Plasmodium falciparum;P
vivax:Plasmodium vivax; RCT: randomized controlled trial; RDT: rapid diagnostic test; TLLIN: targeted long-lasting insecticidal
mosquito nets; ULLIN: universal long-lasting insecticidal mosquito nets; WHO: World Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abeku 2014 Study design did not meet inclusion criteria
Bekele 2012 Study design did not meet inclusion criteria
Diallo 2015 Study design did not meet inclusion criteria
Fullman 2013 Study design did not meet inclusion criteria
Gari 2016 Study design did not meet inclusion criteria
Gimnig 2016 Study design did not meet inclusion criteria
Hamel 2011 Study design did not meet inclusion criteria
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(Continued)
Katureebe 2016 Study design did not meet inclusion criteria
Kitau 2015 Duplicate (data from West 2014)
Lyimo 1991 Study design did not meet inclusion criteria
Matowo 2015 Study design did not meet inclusion criteria
Pinder 2011 Duplicate (study protocol of Pinder 2015)
Pinder 2012 Duplicate (conference abstract of Pinder 2015)
Protopopoff 2007a Study design did not meet inclusion criteria
Protopopoff 2007b Study design did not meet inclusion criteria
Protopopoff 2015a Duplicate (conference abstract of West 2014)
Protopopoff 2015b Duplicate (data from West 2014)
West 2012 Duplicate (conference abstract of West 2014)
West 2015 Study design did not meet inclusion criteria
Zhou 2013 Study design did not meet inclusion criteria
Characteristics of studies awaiting assessment [ordered by study ID]
Chaccour 2018
Methods Study design: cRCT with 2 intervention arms
Study status: ongoing
Unit of allocation: villages
Number of units: 43 clusters per arm
Outcome assessment/surveillance type:
• Community malaria incidence measured through active monthly parasitological surveys in participating
households. 18 children from each cluster aged 6-59 months at time of enumeration recruited. Parasitaemia
confirmed with RDT;
• Incidence rates at the health facility level measured via passive surveillance.
Length of follow-up: September 2016 to December 2018
Adjustment for clustering: yes
Participants Number of participants: cohort of 784 children per arm aged 6-59 months were recruited for monthly active
case detection. For each cross-sectional survey, an independent sample of 770 participants (385 children aged 6-
71 months and 385 children aged ≥ 60 months) were included
Population characteristics: 162,188 participants, with 31,927 (19.7%) under 5years of age
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Chaccour 2018 (Continued)
Withdrawal and loss to follow-up: not reported
Interventions IRS:
Active ingredient and dosage: pirimiphos-methyl at the recommended dosage of 1 g/m²
Formulation: 30% capsule suspension (Actellic 300CS)
Frequency of spraying: yearly
Coverage: aimed for universal coverage
Buffer size between clusters: each cluster had an internal buffer zone of ≥ 1km defined around each cluster’s core
area, and cohort members were only selected from core areas
ITN:
Active ingredient and dosage: nets used at the time from mass distribution campaigns
Coverage: not reported
Compliance: not reported
Control: ITN only as above
Cointerventions: none reported
Outcomes Primary:
Malaria cases averted in children aged 6-59 months at the community level by adding IRS (community incidence)
Cost per malaria case averted in children aged 6-59 months at the community level by adding IRS
Malaria case averted in children aged 6-59 months at the health facility level by adding IRS (health facility
incidence)
Cost per malaria case averted in children aged 6-59 months at the health facility level by adding IRS
Secondary:
Vector densities, human biting rates, sporozoite rates, indoor and outdoor feeding behaviours, prevalence and
intensity of resistance to pyrethroids, and estimates of EIR as measured or estimated through entomological
surveillance
Changes in community-based parasite prevalence
Incremental impact of combining IRS with LLINs, including assessment of the impact of new nets in year 2
Correlation between incidence at community and health facility levels
Correlation between incidence (community and health facility) and prevalence
Changes in malaria prevention methods including net use and in health-seeking behaviour
Location profile Study location:Mopeia is a district in Zambezia, 1 of the most impoverished provinces of Mozambique. Carried
out in all of Mopeia’s villages
Malaria endemicity: highly endemic
EIR: not reported
Population proximity/density: not reported
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An gambiae s.s. and An funestus s.s. although An arabiensis is present as
well
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/endophilic, exophagic/en-
dophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: data from January 2015 in the neighbouring districts of Mocuba and Morrumbala
show pyrethroid resistance (mortality 24 hours after deltamethrin WHO tube test: 52% in Mocuba and 34%
in Morrumbala; mortality after lambda-cyhalothrin: 40% in Mocuba and 33% in Morrumbala) in the localAn
gambiae s.l. population.
Genotypic resistance profile: not reported
Method of mosquito collection: 8 households in each cluster from a subset of 5 villages per arm used light traps
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Chaccour 2018 (Continued)
and human landing catches. Monitoring took place on 3 consecutive nights everymonth leading to 240 collections
per month
Notes
Deressa 2016
Methods Study design: cRCT with 4 intervention arms:
• LLIN + IRS
• LLINs alone
• IRS alone
• control
Study status: ongoing
Unit of allocation: villages
Number of units: 44 clusters per arm, with each cluster comprised of approximately 35 households (about 175
people)
Outcome assessment/surveillance type:malaria incidence based on the results of the RDTs in people with a fever
or history of fever attending health posts by passive case detection. Community-based surveys were conducted
each year to assess anaemia among children aged 5-59 months. In addition, community-based malaria prevalence
surveys were conducted each year on a representative sample of households during the main transmission season
Length of follow-up: 119 weeks from September 2014 to January 2017
Adjustment for clustering: not reported
Participants Number of participants: 34,548 total
Population characteristics: not reported
Withdrawal and loss to follow-up: not reported
Interventions The relevant comparison for this review is LLIN + IRS versus LLINs alone
IRS:
Active ingredient and dosage: propoxur 2 g/m²
Formulation: 50% water-dispersible powder
Frequency of spraying: yearly
Coverage: aimed for 80% coverage as per WHO recommendations
Buffer size between clusters: not reported
ITN:
Active ingredient and dosage: deltamethrin 55 mg (PermaNet 2.0)
Coverage: not reported
Compliance: not reported
Control: ITN only as above
Cointerventions: none reported
Outcomes Primary:
Malaria incidence
Secondary:
Anaemia in children
Malaria prevalence
Mosquito adult density
Sporozoite rate
Changes in insecticide resistance, both phenotype and genotype
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Deressa 2016 (Continued)
Location profile Study location: study was carried out in the Adami Tullu part of the Adami Tullu-Jiddo-Kombolcha woreda in
the East Shewa Zone of the Oromia Regional State in Ethiopia. The capital of the district, Zeway (or Batu), has a
latitude and longitude of 7°56’N 38°42’E with an elevation of 1640 m above sea level. It is located approximately
160 km south of Addis Ababa. The district is set in the Great Rift Valley in south-central Ethiopia, with altitudes
ranging from 1500 m to 2300 m. For villages to be included in the trial, they had to have a relatively easy access,
relatively higher malaria transmission, and located within 5 km from Lake Zeway
Malaria endemicity: seasonal and unstable. The main malaria transmission season occurs between September and
December each year following the heavy rainfall between July and August, whereas the smaller peak occurs during
May and June each year following small rains during March and April
EIR: not reported
Population proximity/density: not reported
Plasmodium spp: P falciparum and P vivax
Vector profile Primary (and secondary) vector species: An arabiensis and An pharoensis
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/endophilic, exophagic/en-
dophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: not reported
Genotypic resistance profile: not reported
Method of mosquito collection: 16 villages (4 per arm) were randomly selected for entomological study, in
which indoor host-seeking mosquitoes were collected by CDC light traps from 4 houses per arm, indoor resting
mosquitoes from 16 houses per arm using pyrethrum spray collection and outdoor resting mosquitoes from 4
artificial pit shelters per arm of the study
Phenotypic insecticide resistance was monitored annually throughout the study period using standard WHO
tube tests. Insecticides used in this test were pyrethroids (deltamethrin, alphacypermethrin, permethrin, and
lambdacyhalothrin) and the carbamates (bendiocarb and propoxur). Resistance intensity was quantified to assess
any change in resistance. Molecular and biochemical analyses were used to identify potential insecticide resistance
mechanisms
Notes
Hamainza 2016
Methods Study design: cluster stepped-wedge design RCT, the study assessed the impact of 4 different IRS insecticide
formulations
Study status: completed
Unit of allocation: village or groups of villages
Number of units: 14 units with mixed interventions
Outcome assessment/surveillance type:
• Active monthly parasitological surveys in participating households. Participants were encouraged to seek
care through passively offered diagnosis and treatment services in-between surveys. Parasitaemia confirmed with
RDT (ICT Malaria P.f. cassette test)
• Entomological observations were made in 15 households in each cluster. Additionally, human landing
catches were conducted both indoors and outdoor
Length of follow-up: 29 months in Luangwa and 26 months in Nyimba, starting from January
Adjustment for clustering: yes
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Hamainza 2016 (Continued)
Participants Number of participants: 25,354 at the start of the study stated in population characteristics; however, figure 2
suggested 84,275
Population characteristics: out of these participants, 29% (7412) were children under the age of 5 years. The
overall cluster populations ranged from 1158 to 3429
Withdrawal and loss to follow-up: Figure 2 in the paper suggested many participants withdrew, no ITT analysis
stated
Interventions IRS:
Active ingredient, dosage, formulation and coverage:
• deltamethrin, wettable granule formulation, 82%
• lambdacyhalothrin, capsule suspension, 61%
• pirimiphos methyl, emulsifiable concentrate, 53%
• pirimiphos methyl, capsule suspension, 69%
Frequency of spraying:
• October 2010: deltamethrin (clusters 4, 5, 6, and 7). Control (1, 2, 3, 8, 9, 10, 11, 12, 13, and 14)
• October 2011: pirimiphos EC (2, 4, 5, 9, 11, and 13); lambdacyhalothrin (6, 7). Control (1, 3, 8, 10, and
12)
• November 2012: pirimiphos CS (8, 9, 10, 12, and 14); February 2013: pirimiphos EC (2, 4, and 5);
Lambdacyhalothrin (6 and 7). Control (1, 2, 3, 11, and 13)
Coverage: in the first 1-6 months’ post IRS implementation (range 0-100%; mean 29.4%)
Buffer size between clusters: not reported
ITN: no mass distribution took place as part of the study; however, ITN use was already high (LLIN use in the
first 1-6 months’ post IRS implementation across all clusters in both arms (range 6.6-100%, mean 68.2%))
Control: ITN as above and areas that had not yet received spraying during the study period and those for which
the last spray round began more than 12 months ago
Cointerventions: intermittent preventive therapy
Outcomes Primary:
Diagnostic positivity for malaria infection, expressed as the proportion of RDT-tested people who were found to
be positive
Secondary:
Indoor-outdoor distribution of human exposure to An funestus bites measured as bites per person per hour
Location profile Study location: Luangwa located in Lusaka and Nyimba located in Eastern provinces, of the Republic of Zambia.
Predominantly rural
Malaria endemicity: perennial
EIR: 70 (for non-users of LLINs)
Population proximity/density: not reported
Plasmodium spp: P falciparum
Vector profile Primary (and secondary) vector species: An funestus
Vector behaviour (nature, stability, adult habitat, peak biting times, exophilic/endophilic, exophagic/en-
dophagic, anthropophilic/zoophilic): not reported
Phenotypic resistance profile: F1 generation from wild-caught mosquitoes were exposed to standard WHO
susceptibility tests using insecticide impregnated papers for the duration of the study (2010-2013). Throughout
the study period, An funestus were consistently susceptible to both malathion and DDT (100% mortality) in both
Luangwa and Nyimba. Moderate resistance to deltamethrin that increased to high resistance in both sites during
the study period. Lambdacyhalothrin showed a similar pattern but was only measured in Luangwa
Genotypic resistance profile: not reported
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Hamainza 2016 (Continued)
Method of mosquito collection: light traps and Ifakara tent traps. Each house was visited once per month for
mosquito trapping. Light traps were placed at the foot end of an occupied sleeping space covered with an LLIN,
hanging approximately 1.5 m above the floor. A tent trap was placed immediately outside, approximately 5 m
away from the house. Traps were set up in the evenings and collection of the captured mosquitoes was done in
the early morning by aspiration. Additionally, human landing catches were conducted both indoors and outdoors
from 18.00 to 06.00 hours
Notes
Abbreviations: An: Anopheles; CDC: Centers for Disease Control and Prevention; cRCT: cluster randomized controlled trial; DDT:
dichloro-diphenyl-trichlorethane; EIR; entomological inoculation rate; ICT: immunochromatographic diagnostic test; IRS: indoor
residual spraying; ITN: insecticide-treated net; ITT: intention to treat; LLIN: long-lasting insecticidal mosquito net; RCT: random-
ized controlled trial; RDT: rapid diagnostic test; WHO: World Health Organization.
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D A T A A N D A N A L Y S E S
Comparison 1. Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus
ITNs alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaria incidence 2 Rate ratio (Random, 95% CI) 0.93 [0.46, 1.86]
2 Malaria parasite prevalence 4 Risk Ratio (Random, 95% CI) 0.67 [0.35, 1.28]
3 Malaria parasite prevalence (net
usage subgroup analysis)
4 Risk Ratio (Random, 95% CI) 0.67 [0.35, 1.28]
3.1 Net usage ≥ 50% 2 Risk Ratio (Random, 95% CI) 0.47 [0.33, 0.67]
3.2 Net usage < 50% 2 Risk Ratio (Random, 95% CI) 0.87 [0.34, 2.22]
4 Anaemia prevalence 2 Risk Ratio (Random, 95% CI) 0.46 [0.18, 1.20]
5 kdr allelic frequency 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Sensitivity analysis with
an estimated intracluster
correlation coefficient (ICC) of
0.01
1 107 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.86, 1.18]
5.2 Sensitivity analysis with
an estimated ICC of 0.05
1 84 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.83, 1.18]
5.3 Sensitivity analysis with
an estimated ICC of 0.1
1 67 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.83, 1.22]
Comparison 2. Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs
alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaria incidence 2 Rate ratio (Random, 95% CI) 1.07 [0.80, 1.43]
2 Malaria parasite prevalence 3 Risk Ratio (Random, 95% CI) 1.11 [0.86, 1.44]
3 Anaemia prevalence 1 Risk Ratio (Random, 95% CI) 1.12 [0.89, 1.40]
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Analysis 1.1. Comparison 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 1 Malaria incidence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 1 Malaria incidence
Study or subgroup log [Rate ratio] Rate ratio Weight Rate ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Corbel 2012 0.2776 (0.1954) 50.1 % 1.32 [ 0.90, 1.94 ]
Kafy 2017 (1) -0.4308 (0.1991) 49.9 % 0.65 [ 0.44, 0.96 ]
Total (95% CI) 100.0 % 0.93 [ 0.46, 1.86 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 6.45, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) IRS with bendiocarb (years 2 % 3)
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Analysis 1.2. Comparison 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 2 Malaria parasite prevalence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 2 Malaria parasite prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Corbel 2012 0.277 (0.1214) 24.9 % 1.32 [ 1.04, 1.67 ]
Kafy 2017 (1) -0.8858 (0.1971) 23.6 % 0.41 [ 0.28, 0.61 ]
Protopopoff 2018 (2) -0.1681 (0.4679) 17.0 % 0.85 [ 0.34, 2.11 ]
Protopopoff 2018 (3) -0.6463 (0.5423) 15.2 % 0.52 [ 0.18, 1.52 ]
West 2014 -0.6829 (0.3777) 19.3 % 0.51 [ 0.24, 1.06 ]
Total (95% CI) 100.0 % 0.67 [ 0.35, 1.28 ]
Heterogeneity: Tau2 = 0.42; Chi2 = 28.95, df = 4 (P<0.00001); I2 =86%
Test for overall effect: Z = 1.21 (P = 0.23)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) IRS with bendiocarb (years 2 % 3)
(2) with pyrethroid-PBO net; estimated ICC of 0.01 used to adjust for clustering
(3) With pyrethroid ITN; estimated ICC of 0.01 used to adjust for clustering
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Analysis 1.3. Comparison 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 3 Malaria parasite prevalence (net usage subgroup analysis).
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 3 Malaria parasite prevalence (net usage subgroup analysis)
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 Net usage≥ 50%
Kafy 2017 (1) -0.8858 (0.1971) 23.6 % 0.41 [ 0.28, 0.61 ]
Protopopoff 2018 (2) -0.6463 (0.5423) 15.2 % 0.52 [ 0.18, 1.52 ]
Protopopoff 2018 (3) -0.1681 (0.4679) 17.0 % 0.85 [ 0.34, 2.11 ]
Subtotal (95% CI) 55.8 % 0.47 [ 0.33, 0.67 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 2.05, df = 2 (P = 0.36); I2 =2%
Test for overall effect: Z = 4.23 (P = 0.000023)
2 Net usage < 50%
Corbel 2012 0.277 (0.1214) 24.9 % 1.32 [ 1.04, 1.67 ]
West 2014 -0.6829 (0.3777) 19.3 % 0.51 [ 0.24, 1.06 ]
Subtotal (95% CI) 44.2 % 0.87 [ 0.34, 2.22 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 5.85, df = 1 (P = 0.02); I2 =83%
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 100.0 % 0.67 [ 0.35, 1.28 ]
Heterogeneity: Tau2 = 0.42; Chi2 = 28.95, df = 4 (P<0.00001); I2 =86%
Test for overall effect: Z = 1.21 (P = 0.23)
Test for subgroup differences: Chi2 = 1.49, df = 1 (P = 0.22), I2 =33%
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) IRS with bendiocarb (years 2 % 3)
(2) With pyrethroid ITN; estimated ICC of 0.01 used to adjust for clustering
(3) with pyrethroid-PBO net; estimated ICC of 0.01 used to adjust for clustering
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Analysis 1.4. Comparison 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 4 Anaemia prevalence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 4 Anaemia prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Protopopoff 2018 (1) -1.7804 (0.7034) 29.3 % 0.17 [ 0.04, 0.67 ]
Protopopoff 2018 (2) 0.162 (1.3019) 11.8 % 1.18 [ 0.09, 15.08 ]
West 2014 -0.46 (0.2996) 58.9 % 0.63 [ 0.35, 1.14 ]
Total (95% CI) 100.0 % 0.46 [ 0.18, 1.20 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 3.37, df = 2 (P = 0.19); I2 =41%
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) With pyrethroid ITN; estimated ICC of 0.01 used to adjust for clustering
(2) with PBO pyrethroid net; estimated ICC of 0.01 used to adjust for clustering
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Analysis 1.5. Comparison 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 5 kdr allelic frequency.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 1 Non-pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 5 kdr allelic frequency
Study or subgroup IRS + ITNs ITNs only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sensitivity analysis with an estimated intracluster correlation coefficient (ICC) of 0.01
Corbel 2012 52/61 39/46 100.0 % 1.01 [ 0.86, 1.18 ]
Subtotal (95% CI) 61 46 100.0 % 1.01 [ 0.86, 1.18 ]
Total events: 52 (IRS + ITNs), 39 (ITNs only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.95)
2 Sensitivity analysis with an estimated ICC of 0.05
Corbel 2012 41/48 31/36 100.0 % 0.99 [ 0.83, 1.18 ]
Subtotal (95% CI) 48 36 100.0 % 0.99 [ 0.83, 1.18 ]
Total events: 41 (IRS + ITNs), 31 (ITNs only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.93)
3 Sensitivity analysis with an estimated ICC of 0.1
Corbel 2012 33/38 25/29 100.0 % 1.01 [ 0.83, 1.22 ]
Subtotal (95% CI) 38 29 100.0 % 1.01 [ 0.83, 1.22 ]
Total events: 33 (IRS + ITNs), 25 (ITNs only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
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Analysis 2.1. Comparison 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 1 Malaria incidence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 1 Malaria incidence
Study or subgroup log [Rate ratio] Rate ratio Weight Rate ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kafy 2017 (1) 0 (0.5213) 7.9 % 1.00 [ 0.36, 2.78 ]
Pinder 2015 0.077 (0.1531) 92.1 % 1.08 [ 0.80, 1.46 ]
Total (95% CI) 100.0 % 1.07 [ 0.80, 1.43 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) IRS with deltamethrin (year 1)
Analysis 2.2. Comparison 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 2 Malaria parasite prevalence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 2 Malaria parasite prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kafy 2017 (1) 0.6719 (0.4203) 9.7 % 1.96 [ 0.86, 4.46 ]
Keating 2011 0.1476 (0.5413) 5.9 % 1.16 [ 0.40, 3.35 ]
Pinder 2015 (2) -0.0879 (0.1792) 47.6 % 0.92 [ 0.64, 1.30 ]
Pinder 2015 (3) 0.2013 (0.2075) 36.8 % 1.22 [ 0.81, 1.84 ]
Total (95% CI) 100.0 % 1.11 [ 0.86, 1.44 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 3.20, df = 3 (P = 0.36); I2 =6%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
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(1) IRS with deltamethrin (year 1)
(2) 2011
(3) 2010
Analysis 2.3. Comparison 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets
(ITNs) versus ITNs alone, Outcome 3 Anaemia prevalence.
Review: Indoor residual spraying for preventing malaria in communities using insecticide-treated nets
Comparison: 2 Pyrethroid-like indoor residual spraying (IRS) plus insecticide-treated nets (ITNs) versus ITNs alone
Outcome: 3 Anaemia prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Pinder 2015 (1) 0.046 (0.1566) 54.1 % 1.05 [ 0.77, 1.42 ]
Pinder 2015 (2) 0.1887 (0.1699) 45.9 % 1.21 [ 0.87, 1.68 ]
Total (95% CI) 100.0 % 1.12 [ 0.89, 1.40 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.38, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IRS + ITNs Favours ITNs only
(1) 2010
(2) 2011
A D D I T I O N A L T A B L E S
Table 1. WHO-recommended insecticides for IRS against malaria vectors
Insecticides and formulations Dosage (g AI/m²)
DDT WP 1-2
Malathion WP 2
Fenitrothion WP 2
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Table 1. WHO-recommended insecticides for IRS against malaria vectors (Continued)
Pirimiphos-methyl WP, EC 1-2
Pirimiphos-methyl CS 1
Bendiocarb WP, WP-SB 0.1-0.4
Propoxur WP 1-2
Alpha-cypermethrin WP, SC, WG-SB 0.02-0.03
Bifenthrin WP 0.025-0.05
Cyfluthrin WP 0.02-0.05
Deltamethrin WP, WG, WG-SB, SC-PE 0.02-0.025
Etofenprox WP 0.1-0.3
Lambda-cyhalothrin WP, CS 0.02-0.03
Abbreviations: AI: active ingredient; CS: capsule suspension; DDT: dichloro-diphenyl-trichlorethane; EC: emulsifiable concentrate;
IRS: indoor residual spraying; SC: suspension concentrate; SC-PE: polymer-enhanced suspension concentrate;WHO:WorldHealth
Organization; WG: water-dispersible granule; WG-SB: water-dispersible granules packaged in water-soluble bags; WP: wettable
powder; WP-SB: wettable powder in sealed water-soluble bags.
Table 2. WHO-recommended long-lasting insecticidal nets
Product name Product type Status of WHO recommendation
DawaPlus 2.0 Deltamethrin coated on polyester Interim
Duranet Alpha-cypermethrin incorporated into polyethylene Full
Interceptor Alpha-cypermethrin coated on polyester Full
LifeNet Deltamethrin incorporated into polypropylene Interim
MAGNet Alpha-cypermethrin incorporated into polyethylene Full
MiraNet Alpha-cypermethrin incorporated into polyethylene Interim
Olyset Net Permethrin incorporated into polyethylene Full
Olyset Plus Permethrin and PBO incorporated into polyethylene Interim
Panda Net 2.0 Deltamethrin incorporated into polyethylene Interim
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Table 2. WHO-recommended long-lasting insecticidal nets (Continued)
PermaNet 2.0 Deltamethrin coated on polyester Full
PermaNet 3.0 Combination of deltamethrin coated on polyester with
strengthened border (side panels), and deltamethrin and
PBO incorporated into polyethylene (roof )
Interim
Royal Sentry Alpha-cypermethrin incorporated into polyethylene Full
SafeNet Alpha-cypermethrin coated on polyester Full
Veeralin Alpha-cypermethrin and PBO incorporated into
polyethylene
Interim
Yahe Deltamethrin coated on polyester Interim
Yorkool Deltamethrin coated on polyester Full
Abbreviations: LLIN: long-lasting insecticidal nets; PBO: piperonyl butoxide; WHO: World Health Organization.
Adapted from WHO 2014b.
Table 3. WHO-recommended insecticide products for treatment of mosquito nets for malaria vector control
Insecticide Formulation Dosage (mg AI/m² of netting)
Alpha-cypermethrin SC 10% 20-40
Cyfluthrin EW 5% 50
Deltamethrin SC 1%; WT 25%; and WT 25% + binder 15-25
Etofenprox EW 10% 200
Lambda-cyhalothrin CS 2.5% 10-15
Permethrin EC 10% 200-500
ICON MAXX (long-lasting lambda-cy-
halothrin formulation)
CS 10% + binder 50-83
Abbreviations: AI: active ingredient; EC: emulsifiable concentrate; EW: emulsion, oil in water; CS: capsule suspension; SC: suspension
concentrate; WT: water dispersible tablet; WHO: World Health Organization.
Adapted from WHO 2014c.
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Table 4. Characteristics of indoor residual spraying
Study Active
ingredient, formu-
lation, and dose
Frequency of ap-
plication
Coverage Who carried out
the spraying
Vector species
Comparison 1: IRS using non-pyrethroid-like insecticides plus ITNs versus ITNs alone
Corbel 2012 Bendiocarb
80% wettable pow-
der (FICAM 80,
Bayer) 400 mg/m²
Every 8 months,
June 2008 to De-
cember 2009
Aimed for 80% Unreported An gambiae s.l. and
An funestus s.l.
Kafy 2017
(Years 2 and 3)
Bendiocarb
80% wettable pow-
der (FICAM 80,
Bayer) 200 mg/m²
Twice a year, August
and late December,
2013 and 2014
2013: 82%
2014: 83%
Unreported An gambiae s.l. and
An funestus s.l.
Protopopoff 2018 Pirimiphos-
methyl 30% capsule
suspension (Actellic
300CS) 1 g active
ingredient/m²
Once, February
2015
Standard ITN arm:
0.5% (95% CI 0.1
to 2.0)
Standard ITN + IRS
arm: 94% (95% CI
92 to 96)
Pyrethroid-PBO
net arm: 4% (95%
CI 0.5 to 29)
Pyrethroid-PBO
net + IRS arm: 94%
(95% CI 87 to 97)
Buffer size between
clusters: minimum
outer buffer zone of
300 m. Only the in-
ner core area was
used for the mea-
surement of study
outcomes
Unreported An gambiaes.s., An
arabiensis and An fu-
nestus
West 2014 Bendiocarb
80% wettable pow-
der (FICAM 80,
Bayer) 400mg/m²
Twice De-
cember 2011 to Jan-
uary 2012 and April
2012 to May 2012
Aimed for 80% (ac-
tual coverage was
89.3-92.1%)
RTI International
on behalf of PMI
An gambiae s.s. and
An arabiensis
Comparison 2: IRS using pyrethroid-like insecticides plus ITNs versus ITNs alone
Kafy 2017
(Year 1)
Deltamethrin
(25 mg/m², formu-
lation not reported,
Chema Industries)
Twice, in August
and late December
2012
99% Unreported An gambiae s.l. and
An funestus s.l.
64Indoor residual spraying for preventing malaria in communities using insecticide-treated nets (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Table 4. Characteristics of indoor residual spraying (Continued)
Keating 2011 DDTwettable pow-
der 1-2 g active in-
gredient/m²
Once, June-July
2009
Aimed for 80% (84.
8%
of households sam-
pled sprayed within
12 months)
Unreported An arabiensis and An
gambiae s.s.
Pinder 2015 DDT 75% wettable
powder (Hindustan
Insecticides) 2 g ac-
tive ingredient/m²
Once per year, July
2010 and July-Au-
gust 2011
Aimed for 80% (ac-
tual coverage was
83-86%)
Operators from the
Gambian Na-
tional Malaria Con-
trol Programme and
team leaders from
the regional health
team
An gambiae s.l.
Abbreviations: CI: confidence interval; DDT: dichloro-diphenyl-trichlorethane; IRS: indoor residual spraying; ITN: insecticide-treated
net; PBO: piperonyl butoxide.
Table 5. ITN coverage and compliance
Study Arm Coverage measure Coverage:
mean (95%CI) un-
less stated other-
wisea
Compliance mea-
sure
Compliance
Comparison 1: IRS using non-pyrethroid-like insecticides plus ITNs versus ITNs alone
Corbel 2012 Control Total number
of hung nets relative
to the total number
of sleeping units
38% (36 to 41)
Low
Proportion of chil-
dren aged < 6 years
sleeping under the
net the night preced-
ing the visit
Mean (95% CI):
43% (40 to 45)
Low
Intervention 45% (43 to 48)
Low
Mean (95% CI):
43% (40 to 46)
Low
Kafy 2017 Control An annual interven-
tion assessment sur-
vey on household
net ownership
2013: 82.1%
2014: 98.6%
High
Defined as the pro-
portion of affirma-
tive responses to the
question “Did this
child sleep under an
ITN last night?”
2013: 74%
2014: 82%
High
Intervention 2013: 75%
2014: 82%
High
Protopopoff 2018 Standard ITNs Household owning
≥ 1 LLIN (study
LLIN or any other
LLIN)
At
9 months’ postinter-
vention: 97% (95%
CI 93 to 99)
High
Residents declaring
using
an ITN the previous
night (study ITN or
any other ITN)
At
9 months’ postinter-
vention: 80% (95%
CI 75 to 85)
High
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Table 5. ITN coverage and compliance (Continued)
Standard ITNs +
IRS
At
9 months’ postinter-
vention: 76% (95%
CI 70 to 80)
Moderate
At
9 months’ postinter-
vention: 76% (95%
CI 70 to 80)
Moderate
Pyrethroid-PBO net At 9 months postin-
tervention: 98%
(95% CI 97 to 99)
High
At
9 months’ postinter-
vention: 78% (95%
CI 73 to 82)
Moderate
Pyrethroid-PBO net
+ IRS
At
9 months’ postinter-
vention: 98% (95%
CI 95 to 99)
High
At
9 months’ postinter-
vention: 77% (95%
CI 70 to 83)
Moderate
West 2014 Control % of households
with ≥ 1 ITN per
sleeping space
February-March:
52.2 (47.8 to 56.5)
June-July: 51.6 (47
to 56)
October-December:
52.8 (47.6 to 58)
Moderate
% of study children
that reported sleep-
ing under an ITN
the night previous to
the survey
February-March:
46.6 (41.7 to 51.6)
June-July: 40.7 (34.
7 to 47)
October-December:
36 (29.8 to 42.6)
Low
Intervention February-March:
57.2 (53.6 to 60.7)
June-July: 57.4 (54
to 60.9)
October-December:
56.8 (51.7 to 61.8)
Moderate
February-March: 53
(47.5 to 58.3)
June-July: 44.1 (39.
2 to 49.2)
October-December:
36.1 (31 to 41.5)
Low
Comparison 2: IRS using pyrethroid-like insecticides plus ITNs versus ITNs alone
Kafy 2017 Control An annual interven-
tion assessment sur-
vey on household
net ownership
99.6%
High
Defined as the pro-
portion of affirma-
tive responses to the
question “Did this
child sleep under an
ITN last night?”
79%
High
Intervention 79%
High
Keating 2011 Control Measured as people
living in household
owning ≥ 1 ITN
72% (70.2 to 73.7)
Moderate
Measured as people
using ITN in the
previous night
Mean (95% CI): 46.
2 (43.9 to 48.6)
Low
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Table 5. ITN coverage and compliance (Continued)
Intervention 75.8% (74.2 to 77.
4)
Moderate
Mean (95% CI): 50.
7% (48.6 to 52.8)
Moderate
Pinder 2015 Control Not reported Not reported Measured as people
using ITN in the
previous night
Mean average across
all clusters:
2011: 92%
2012: 96%
High
Intervention Mean average across
all clusters:
2011: 89%
2012: 93%
High
Abbreviations: CI: confidence interval; IRS: indoor residual spraying; ITN: insecticide-treated net; LLIN: long-lasting insecticidal
mosquito net.
aCoverage and compliance cutoffs (low, moderate, and high) prespecified in protocol.
Table 6. Entomological inoculation rate results
Trial Methods of EIR mea-
surement
Comparison Mean EIR (95% CI)
IRS + ITNs ITNs alone
Comparison 1: IRS using non-pyrethroid-like insecticides + ITNs versus ITNs alone
Corbel 2012 Mean number of infected
bites per man per year
(estimated from the num-
ber of anopheline vectors
caught using human land-
ing catches and the pro-
portion of anopheline vec-
tors infective)
IRS with standard ITN
versus standard ITN alone
7.3
(3.8 to 14.2)
9.4
(5.1 to 17.1)
Protopopoff 2018 Mean number of infected
bites per household per
night
(the number of infective
anopheline vectors caught
using light traps in 1 night
per month was used as a
proxy for this)
IRS with standard ITN
versus standard ITN alone
0.05
(n = 413)
1.76
(n = 449)
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Table 6. Entomological inoculation rate results (Continued)
IRS with pyrethroid-PBO
net versus pyrethroid-
PBO net alone
0.00
(n = 459)
0.26
(n = 452)
West 2014 Mean number of infected
bites per household per
month
(estimated from the num-
ber of infective anopheline
vectors caught using light
traps in 1 night)
IRS with standard ITN
versus standard ITN alone
1.3
(0.4 to 4.4)
1.1
(0.4 to 2.8)
Comparison 2: IRS using pyrethroid-like insecticides + ITNs versus ITNs alone
Pinder 2015 Mean number of infected
bites per person per trans-
mission season
(estimated from the num-
ber of anopheline vec-
tors caught using light
traps and the proportion
of anopheline vectors in-
fective)
IRS with standard
ITN versus standard ITN
alone: 2010
1.08
(0.16 to 4.02)
2.44
(0.69 to 6.39)
IRS with standard
ITN versus standard ITN
alone: 2011
0.29
(0.00 to 2.66)
1.45
(0.15 to 5.69)
Abbreviations: CI: confidence interval; EIR: entomological inoculation rate; IRS: indoor residual spraying; ITNs: insecticide-treated
nets; n: number of participants; PBO: piperonyl butoxide.
Table 7. Sporozoite rate results
Trial Assessment
method
Comparison Reported results Effect size (95% CIs)
IRS + ITNs ITNs alone IRS + ITNs ITNs alone
Comparison 1: IRS using non-pyrethroid-like insecticides plus ITNs versus ITNs alone
Corbel 2012 % of An gambiae
s.l. caught from
human land-
ing catches with
sporozoites
(ELISA)
IRS with stan-
dard ITN versus
standard ITN
alone
3.22%
(95% CI 1.76 to
4.68)
2.83%
(95% CI 1.69 to
3.97)
Not reported
Protopopoff
2018
% of An gambiae
s.l. caught from
light traps with
sporozoites
(ELISA)
IRS with stan-
dard ITN versus
standard ITN
alone
0.4%
(1/269)
2.8%
(19/683)
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Table 7. Sporozoite rate results (Continued)
IRS
with pyrethroid-
PBO net versus
pyrethroid-PBO
net alone
0.0%
(0/343)
0.7%
(2/305)
West 2014 IRS with stan-
dard ITN versus
standard ITN
alone
1.8%
(95% CI 0.5 to
6.2; n = 717)
2.5%
(95% CI 2.1 to
3.1; n = 3059)
OR 0.72
(0.21 to 2.53)
Comparison 2: IRS using pyrethroid-like insecticides plus ITNs versus ITNs alone
Pinder 2015 % of An gambiae
s.l. caught from
light traps with
sporozoites
(ELISA)
IRS with stan-
dard ITN versus
standard ITN
alone: 2010
0.19%
(4/2131)
0.32%
(9/2829)
RR 0.59
(0.18 to 1.91)
IRS with stan-
dard ITN versus
standard ITN
alone: 2011
0.65%
(5/773)
0.09%
(1/1131)
RR 7.32
(0.86 to 62.5)
Abbreviations: CI: confidence interval; ELISA: enzyme-linked immunosorbent assay; IRS: indoor residual spraying; ITN: insecticide-
treated net; MD: mean difference; OR: odds ratio; PBO: piperonyl butoxide; RR: risk ratio.
aNot adjusted for clustering.
Table 8. Adult mosquito density results
Trial Methods of
adult mosquito
density
measurement
Comparison Reported results
Mean (95% CIs)
Effect size (95% CIs)
IRS + ITNs ITNs alone IRS + ITNs ITNs alone
Comparison 1: IRS using non-pyrethroid-like insecticides + ITNs versus ITNs alone
Corbel 2012 Mean number of
bites perman per
year fromhuman
landing catches
(16 person-
nights per village
(total 28 villages
di-
vided evenly into
4 arms) per sur-
vey (total 8 sur-
veys))
IRS with stan-
dard ITN versus
standard ITN
alone
228
(149 to 348; n =
896)
331
(218 to 504; n =
896)
Rate ratio: 0.69 (0.38 to 1.25)
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Table 8. Adult mosquito density results (Continued)
Protopopoff
2018
Mean number of
vectors caught in
light traps per
night per house-
hold
(7 randomly se-
lected houses per
cluster (to-
tal 48 clusters di-
vided evenly into
4 arms) for 1
night per month
(total 8 months)
)
IRS with stan-
dard ITN versus
standard ITN
alone
2.37
(n = 425)
2.83
(n = 471)
Not reported
IRS
with pyrethroid-
PBO net versus
pyrethroid-PBO
net alone
1.85
(n = 493)
1.84
(n = 468)
West 2014 Mean number of
An gambiae s.l.
per house per
night
(8 randomly se-
lected houses per
cluster (total 40
clusters divided
evenly into 2
arms) for 1 night
per month (total
21 months))
IRS with stan-
dard ITN versus
standard ITN
alone
0.4
(0.1 to 1.4; n =
1893)
1.7
(0.5 to 6.4; n =
1892)
Rate ratio 0.23 (0.04 to 1.44)
Comparison 2: IRS using pyrethroid-like insecticides + ITNs versus ITNs alone
Pinder 2015 Mean number of
An gambiae s.
l. per trap per
night
(6 sen-
tinel rooms in 32
clusters)
IRS with stan-
dard ITN versus
standard ITN
alone: 2010 light
traps
3.70
(2.03 to 5.37)
4.92
(3.05 to 6.79)
MD -1.22
(-3.58 to 1.14)
IRS with stan-
dard ITN versus
standard
ITN alone: 2010
exit traps
0.40
(-0.15 to 0.66)
0.54
(0.18 to 0.89)
MD -0.13
(-0.54 to 0.28)
IRS with stan-
dard ITN versus
standard ITN
alone: 2011 light
traps
1.27
(0.39 to 2.15)
1.96
(0.69 to 3.24)
MD -0.69
(-2.15 to 0.77)
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Table 8. Adult mosquito density results (Continued)
IRS with stan-
dard ITN versus
standard
ITN alone: 2011
exit traps
0.06
(0.01 to 0.10)
0.46
(-0.23 to 1.15)
MD -0.40
(-1.05 to 0.25)
Abbreviations: CI: confidence interval; IRS: indoor residual spraying; ITNs: insecticide-treated nets; MD: mean difference; PBO:
piperonyl butoxide.
A P P E N D I C E S
Appendix 1. Search strategies
PubMed search set Search terms
1 Malaria [ Mesh], Title/Abstract
2 Mosquito* Title/Abstract
3 “Anopheles”[Mesh]
4 1 or 2 or 3
5 “indoor residual spraying” or IRS* Title/Abstract
6 “house spray*” Title/Abstract
7 ( “Insecticides/administration and dosage”[Mesh] or “Insecticides/supply and distribution”[Mesh] or “Insec-
ticides/therapeutic use”[Mesh] ) or “Pyrethrins”[Mesh]
8 malathionor fenitrothionor pirimiphos-methyl or bendiocarb or propoxur or alpha-cypermethrin or bifenthrin
or cyfluthrin or deltamethrin or etofenprox or lambda-cyhalothrin or DDT Title/Abstract
9 “insecticide-treated bednet*” or insecticide-treated net*” or “Long-lasting insecticidal net*” or LLIN* or ITN*
or LN*or “bed net*”or “long-lasting net*” Title/Abstract
10 “Insecticide-Treated Bednets” [Mesh]
11 (“Mosquito Control/instrumentation”[Mesh] OR “Mosquito Control/methods”[Mesh])
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(Continued)
12 5 or 6 or 7 or 8
13 9 or 10 or 11
14 4 and 12 and 13
15 “Randomized Controlled Trial” [Publication Type] OR “Controlled Clinical Trial” [Publication Type]
16 single-blind* or double-blind* Title/Abstract
17 randomized or placebo or trial or groups or randomly Title/Abstract
18 “before and after ” Title/Abstract
19 “Epidemiologic Studies”[Mesh]
20 “time series” Title/Abstract
21 20 OR 19 OR 18 OR 17 OR 16 OR 15
22 21 AND 14
Embase
1 malaria/ or malaria.mp.
2 Anopheles/ or anopheles.mp.
3 mosquito*.mp. or mosquito/
4 1 or 2 or 3
5 indoor residual spraying.mp. or indoor residual spraying/
6 indoor residual spray.mp.
7 house spray.mp.
8 house spraying.mp.
9 IRS.ab. or IRS.ti.
10 (malathion or fenitrothion or pirimiphos-methyl or bendiocarb or propoxur or alpha-cypermethrin or bifenthrin or cyfluthrin or
deltamethrin or etofenprox or lambda-cyhalothrin or DDT).mp.
11 insecticide/ct, ad, cb, cm, dt [Clinical Trial, Drug Administration, Drug Combination, Drug Comparison, Drug Therapy]
12 pyrethroid/ct, ad, cb, cm, dt [Clinical Trial, Drug Administration, Drug Combination, Drug Comparison, Drug Therapy]
13 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12
14 4 and 13
15 (Net* or bednet* or ITN* or LLIN* or “Insecticide-Treated Bednet*” or “Insecticide-Treated net*”).mp. [mp=title, abstract, heading
word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word]
16 bed net/
17 insecticide treated net/
18 15 or 16 or 17
19 14 and 18
20 randomized controlled trial/ or controlled clinical trial/
21 (randomized or randomised or placebo or double-blind* or single-blind*).mp.
22 epidemiology/
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23 (before and after study).mp
24 time series.mp. or time series analysis/
25 field study.mp. or field study/
26 prospective study.mp. or prospective study/
29 20 or 21 or 22 or 23 or 24 or 27 or 28
30 19 and 29
LILACS
(tw:(indoor residual spraying OR irs OR house spraying)) AND (tw:(bednets OR nets OR itn )) AND (tw:(malaria ORmosquito OR
anopheles)) AND (tw:(randomized OR controlled OR trial OR comparison OR compared ))
Cochrane Central Register of Controlled Trials
Issue 3 of 12, April 2019
ID Search Hits
#1 MeSH descriptor: [Malaria] explode all trees
#2 malaria:ti,ab,kw (Word variations have been searched)
#3 anopheles
#4 MeSH descriptor: [Anopheles] explode all trees
#5 mosquito*
#6 #1 or #2 or #3 or #4 or #5
#7 “indoor residual spray”
#8 “indoor residual spraying”
#9 “house spray*”
#10 IRS
#11 malathion or fenitrothion or pirimiphos-methyl or bendiocarb or propoxur or alpha-cypermethrin or bifenthrin or cyfluthrin or
deltamethrin or etofenprox or lambda-cyhalothrin or DDT
#12 MeSH descriptor: [Insecticides] explode all trees and with qualifier(s): [Administration & dosage - AD, Supply & distribution -
SD, Therapeutic use - TU]
#13 MeSH descriptor: [Pyrethrins] explode all trees and with qualifier(s): [Administration & dosage - AD, Supply & distribution -
SD, Therapeutic use - TU]
#14 #7 or #8 or #9 or #10 or #11 or #12 or #13
#15 Net* or bednet* or ITN* or LLIN* or “Insecticide-Treated Bednet*” or “Insecticide-Treated net*”
#16 MeSH descriptor: [Insecticide-Treated Bednets] explode all trees
#17 #15 or #16
#18 #6 and #14 and #17
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We amended the title from ‘The combination of indoor residual spraying with insecticide-treated nets versus insecticide-treated nets
alone for preventing malaria’ to ‘Indoor residual spraying for preventing malaria in communities using insecticide-treated nets’.
In the protocol, we initially limited the outcome of insecticide resistance to the specific insecticide used for IRS (Choi 2017). However,
during the extraction process, it became apparent that resistance to pyrethroid insecticides was also an important outcome in trials
using non-pyrethroid-like insecticides for IRS. Therefore, we extracted resistance outcome data for both classes of insecticide.
We also made changes to the way that we subgrouped trials. Initially, we intended to include all comparisons of IRS plus ITNs versus
ITNs alone in one analysis, regardless of the target site of the insecticide used for IRS. However, we prespecified that we would subgroup
the data by this target site to explore potential causes of heterogeneity. Following referee feedback, it became clear that the most
important policy question was to assess the effectiveness of combining ITNs with a non-pyrethroid-like IRS. Therefore we decided not
to conflate this analysis with that of the pyrethroid-like IRS interventions, and instead presented two separate comparisons.
We stated in the protocol that we would perform the following subgroup analyses to investigate heterogeneity.
• Use of LLINs/ITNs defined by individual use from the previous night:
◦ high (80% to 100%);
◦ moderate (50% to 79%);
◦ low (less than 50%).
• Coverage of IRS:
◦ high (80% to 100%);
◦ moderate (50% to 79%);
74Indoor residual spraying for preventing malaria in communities using insecticide-treated nets (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
◦ low (less than 50%).
• Seasonality of malaria:
◦ perennial;
◦ seasonal;
◦ epidemic.
Due to few studies and lack of data surrounding certain subgroups, we were only able to perform the following subgroup analysis.
• Use of LLINs/ITNs defined by individual use from the previous night:
◦ high (50% or more);
◦ low (less than 50%).
Finally, we originally stated in the protocol that a P value less than 0.05 indicated statistically significant differences between subgroups
but we have amended this to less than 0.1.
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